Quest Diagnostics, Inc.. (DGX) NEW YORK STOCK EXCHANGE INC.
$123.40 (1.18) (-0.95%)
Market Cap: $13.85B
As of 09/27/23 04:01 PM EDT. Market closed.

Quest Diagnostics, Inc.. (DGX)
NEW YORK STOCK EXCHANGE INC.
$123.40
(1.18) (-0.95%)
Market Cap: $13.85B
As of 09/27/23 04:01 PM EDT. Market closed.
quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united ... read more
quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
GARDNER MARK A | SVP of Molecular Gen & Oncol | Sep 25, 2023 | Option Exercise | $126.22 | 116 | 14,642 | 2,805 | Sep 27, 2023, 05:54 PM |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Aug 15, 2023 | Option Exercise | $135.23 | 74 | 10,007 | 11,294 | Aug 17, 2023, 04:39 PM |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Jul 25, 2023 | Option Exercise | $144.59 | 25 | 3,615 | 11,355 | Jul 27, 2023, 04:43 PM |
Gregg Vicky B | Director | Jul 25, 2023 | Option Exercise | $144.59 | 78 | 11,278 | 18,649 | Jul 27, 2023, 04:41 PM |
Plewman Patrick | SVP for Diagnostic Services | Jul 25, 2023 | Option Exercise | $144.59 | 44 | 6,362 | 12,397 | Jul 27, 2023, 04:40 PM |
SAMAD SAM | Executive Vice President & CFO | Jul 14, 2023 | Option Exercise | $140.18 | 3,909 | 547,964 | 16,475 | Jul 17, 2023, 04:37 PM |
Plewman Patrick | SVP for Diagnostic Services | Apr 24, 2023 | Option Exercise | $143.08 | 44 | 6,296 | 12,319 | Apr 25, 2023, 05:50 PM |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Apr 24, 2023 | Option Exercise | $143.08 | 25 | 3,577 | 11,295 | Apr 25, 2023, 05:47 PM |
Gregg Vicky B | Director | Apr 24, 2023 | Option Exercise | $143.08 | 72 | 10,302 | 17,202 | Apr 25, 2023, 05:45 PM |
Plewman Patrick | SVP for Diagnostic Services | Mar 24, 2023 | Option Exercise | $134.25 | 99 | 13,291 | 12,258 | Mar 27, 2023, 04:39 PM |
DELANEY MARK E | SVP & Chief Commercial Officer | Mar 24, 2023 | Option Exercise | $134.25 | 170 | 22,823 | 3,480 | Mar 27, 2023, 04:38 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 06, 2023 | Option Exercise | $147.86 | 8,595 | 1,270,857 | 47,122 | Mar 08, 2023, 04:39 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 06, 2023 | Option Exercise | $147.86 | 3,841 | 567,930 | 43,281 | Mar 08, 2023, 04:39 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 07, 2023 | Sale | $140.55 | 4,754 | 668,175 | 38,527 | Mar 08, 2023, 04:39 PM |
Doherty Catherine T. | SVP, Regional Businesses | Mar 06, 2023 | Option Exercise | $147.86 | 9,917 | 1,466,328 | 77,727 | Mar 08, 2023, 04:38 PM |
Doherty Catherine T. | SVP, Regional Businesses | Mar 06, 2023 | Option Exercise | $147.86 | 4,610 | 681,635 | 73,117 | Mar 08, 2023, 04:38 PM |
Doherty Catherine T. | SVP, Regional Businesses | Mar 07, 2023 | Sale | $140.55 | 5,307 | 745,899 | 67,810 | Mar 08, 2023, 04:38 PM |
Plewman Patrick | SVP for Diagnostic Services | Mar 06, 2023 | Option Exercise | $147.86 | 2,579 | 381,331 | 13,145 | Mar 08, 2023, 04:36 PM |
Plewman Patrick | SVP for Diagnostic Services | Mar 06, 2023 | Option Exercise | $147.86 | 799 | 118,140 | 12,357 | Mar 08, 2023, 04:36 PM |
DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Mar 06, 2023 | Option Exercise | $147.86 | 1,918 | 283,595 | 34,178 | Mar 08, 2023, 04:35 PM |
DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Mar 06, 2023 | Option Exercise | $147.86 | 682 | 100,841 | 33,497 | Mar 08, 2023, 04:35 PM |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Mar 06, 2023 | Option Exercise | $147.86 | 1,985 | 293,502 | 11,824 | Mar 08, 2023, 04:34 PM |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Mar 06, 2023 | Option Exercise | $147.86 | 583 | 86,202 | 11,241 | Mar 08, 2023, 04:34 PM |
Davis J. E. | CEO and President | Mar 06, 2023 | Option Exercise | $147.86 | 15,204 | 2,248,063 | 110,670 | Mar 08, 2023, 04:31 PM |
Davis J. E. | CEO and President | Mar 06, 2023 | Option Exercise | $147.86 | 8,036 | 1,188,203 | 102,634 | Mar 08, 2023, 04:31 PM |
RUSCKOWSKI STEPHEN H | Director | Mar 06, 2023 | Option Exercise | $147.86 | 82,631 | 12,217,820 | 428,201 | Mar 08, 2023, 04:29 PM |
RUSCKOWSKI STEPHEN H | Director | Mar 06, 2023 | Option Exercise | $147.86 | 38,604 | 5,707,987 | 389,597 | Mar 08, 2023, 04:29 PM |
Doherty Catherine T. | SVP, Regional Businesses | Mar 03, 2023 | Sale | $140.63 | 717 | 100,832 | 67,810 | Mar 06, 2023, 05:08 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 01, 2023 | Option Exercise | $140.69 | 320 | 45,021 | 39,120 | Mar 03, 2023, 04:51 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 02, 2023 | Sale | $138.54 | 593 | 82,154 | 38,527 | Mar 03, 2023, 04:51 PM |
Plewman Patrick | SVP for Diagnostic Services | Mar 01, 2023 | Option Exercise | $140.69 | 90 | 12,662 | 10,566 | Mar 03, 2023, 04:47 PM |
DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Mar 01, 2023 | Option Exercise | $140.69 | 68 | 9,567 | 32,260 | Mar 03, 2023, 04:42 PM |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Mar 01, 2023 | Option Exercise | $140.69 | 65 | 9,145 | 9,839 | Mar 03, 2023, 04:40 PM |
Davis J. E. | CEO and President | Feb 23, 2023 | Option Exercise | $147.86 | 1,473 | 217,798 | 79,315 | Feb 27, 2023, 04:56 PM |
RUSCKOWSKI STEPHEN H | Director | Feb 23, 2023 | Option Exercise | $147.86 | 5,826 | 861,432 | 329,007 | Feb 27, 2023, 04:54 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 23, 2023 | Option Exercise | $147.86 | 811 | 119,914 | 38,413 | Feb 27, 2023, 04:49 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 24, 2023 | Sale | $141.42 | 1,415 | 200,109 | 39,440 | Feb 27, 2023, 04:49 PM |
Plewman Patrick | SVP for Diagnostic Services | Feb 23, 2023 | Option Exercise | $147.86 | 245 | 36,226 | 8,737 | Feb 27, 2023, 04:47 PM |
DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Feb 23, 2023 | Option Exercise | $147.86 | 188 | 27,798 | 31,825 | Feb 27, 2023, 04:46 PM |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Feb 23, 2023 | Option Exercise | $147.86 | 195 | 28,833 | 7,810 | Feb 27, 2023, 04:45 PM |
Doherty Catherine T. | SVP, Regional Businesses | Feb 23, 2023 | Option Exercise | $147.86 | 962 | 142,241 | 66,771 | Feb 27, 2023, 04:42 PM |
Doherty Catherine T. | SVP, Regional Businesses | Feb 24, 2023 | Sale | $141.42 | 1,690 | 239,000 | 68,919 | Feb 27, 2023, 04:42 PM |
Gregg Vicky B | Director | Feb 01, 2023 | Option Exercise | $146.75 | 64 | 9,392 | 17,130 | Feb 03, 2023, 04:40 PM |
Plewman Patrick | SVP for Diagnostic Services | Feb 01, 2023 | Option Exercise | $146.75 | 27 | 3,962 | 8,982 | Feb 03, 2023, 04:38 PM |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Feb 01, 2023 | Option Exercise | $146.75 | 13 | 1,908 | 8,005 | Feb 03, 2023, 04:36 PM |
RING TIMOTHY M | Director | Dec 01, 2022 | Option Exercise | $57.39 | 2,025 | 116,214 | 26,174 | Dec 05, 2022, 04:40 PM |
RING TIMOTHY M | Director | Dec 01, 2022 | Sale | $152.50 | 2,025 | 308,813 | 24,149 | Dec 05, 2022, 04:40 PM |
Doherty Catherine T. | SVP, Regional Businesses | Nov 28, 2022 | Option Exercise | $86.63 | 40,765 | 3,531,472 | 108,498 | Nov 29, 2022, 04:35 PM |
Doherty Catherine T. | SVP, Regional Businesses | Nov 28, 2022 | Sale | $149.18 | 40,765 | 6,081,264 | 91,140 | Nov 29, 2022, 04:35 PM |
RING TIMOTHY M | Director | Nov 01, 2022 | Option Exercise | $61.07 | 2,000 | 122,136 | 25,933 | Nov 02, 2022, 04:32 PM |
RING TIMOTHY M | Director | Nov 01, 2022 | Sale | $144.06 | 2,000 | 288,120 | 24,149 | Nov 02, 2022, 04:32 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Oct 26, 2022 | Option Exercise | $53.79 | 15,497 | 833,598 | 47,503 | Oct 27, 2022, 05:35 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Oct 26, 2022 | Sale | $145.00 | 15,497 | 2,247,065 | 32,013 | Oct 27, 2022, 05:35 PM |
Gregg Vicky B | Director | Oct 19, 2022 | Option Exercise | $127.67 | 74 | 9,447 | 17,066 | Oct 21, 2022, 04:34 PM |
RING TIMOTHY M | Director | Oct 03, 2022 | Option Exercise | $61.22 | 2,000 | 122,450 | 25,933 | Oct 04, 2022, 04:34 PM |
RING TIMOTHY M | Director | Oct 03, 2022 | Sale | $123.39 | 2,000 | 246,780 | 23,933 | Oct 04, 2022, 04:34 PM |
RING TIMOTHY M | Director | Sep 01, 2022 | Option Exercise | $61.22 | 2,000 | 122,450 | 25,933 | Sep 06, 2022, 07:04 PM |
RING TIMOTHY M | Director | Sep 01, 2022 | Sale | $125.02 | 2,000 | 250,040 | 23,933 | Sep 06, 2022, 07:04 PM |
RING TIMOTHY M | Director | Aug 01, 2022 | Option Exercise | $60.85 | 2,000 | 121,709 | 25,933 | Aug 02, 2022, 04:25 PM |
RING TIMOTHY M | Director | Aug 01, 2022 | Sale | $136.04 | 2,000 | 272,080 | 23,933 | Aug 02, 2022, 04:25 PM |
Gregg Vicky B | Director | Jul 20, 2022 | Option Exercise | $134.47 | 70 | 9,413 | 16,992 | Jul 21, 2022, 04:33 PM |
RING TIMOTHY M | Director | Jul 01, 2022 | Option Exercise | $57.46 | 2,000 | 114,911 | 25,933 | Jul 05, 2022, 04:35 PM |
RING TIMOTHY M | Director | Jul 01, 2022 | Sale | $133.47 | 2,000 | 266,940 | 23,933 | Jul 05, 2022, 04:35 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | May 25, 2022 | Option Exercise | $93.46 | 24,891 | 2,326,334 | 349,687 | May 26, 2022, 04:32 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | May 25, 2022 | Sale | $140.89 | 24,891 | 3,506,934 | 339,864 | May 26, 2022, 04:32 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | May 24, 2022 | Option Exercise | $94.20 | 282,408 | 26,601,579 | 491,115 | May 25, 2022, 04:31 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | May 23, 2022 | Option Exercise | $94.26 | 77,466 | 7,302,052 | 377,401 | May 25, 2022, 04:31 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | May 24, 2022 | Sale | $140.12 | 282,408 | 39,571,320 | 334,833 | May 25, 2022, 04:31 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | May 23, 2022 | Sale | $140.17 | 77,466 | 10,858,220 | 336,133 | May 25, 2022, 04:31 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | May 18, 2022 | Option Exercise | $136.98 | 8 | 1,096 | 32,006 | May 20, 2022, 04:44 PM |
Gregg Vicky B | Director | Apr 18, 2022 | Option Exercise | $134.88 | 61 | 8,228 | 15,630 | May 20, 2022, 04:31 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | May 17, 2022 | Option Exercise | $66.51 | 50,604 | 3,365,672 | 89,828 | May 19, 2022, 04:40 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | May 17, 2022 | Sale | $139.97 | 50,604 | 7,082,991 | 39,224 | May 19, 2022, 04:40 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Mar 07, 2022 | Option Exercise | $130.09 | 2,516 | 327,306 | 32,718 | Mar 09, 2022, 04:58 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Mar 07, 2022 | Option Exercise | $130.09 | 914 | 118,902 | 32,011 | Mar 09, 2022, 04:58 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 07, 2022 | Option Exercise | $130.09 | 70,184 | 9,130,236 | 367,403 | Mar 09, 2022, 04:53 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 07, 2022 | Option Exercise | $130.09 | 32,570 | 4,237,031 | 334,833 | Mar 09, 2022, 04:53 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 07, 2022 | Option Exercise | $130.09 | 11,544 | 1,501,759 | 50,768 | Mar 09, 2022, 04:50 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 07, 2022 | Option Exercise | $130.09 | 5,316 | 691,558 | 45,452 | Mar 09, 2022, 04:50 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 08, 2022 | Sale | $135.21 | 6,228 | 842,088 | 39,224 | Mar 09, 2022, 04:50 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 07, 2022 | Option Exercise | $130.09 | 20,780 | 2,703,270 | 109,456 | Mar 09, 2022, 04:48 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 07, 2022 | Option Exercise | $130.09 | 10,475 | 1,362,693 | 98,981 | Mar 09, 2022, 04:48 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Mar 07, 2022 | Option Exercise | $130.09 | 16,162 | 2,102,515 | 56,338 | Mar 09, 2022, 04:44 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Mar 07, 2022 | Option Exercise | $130.09 | 7,947 | 1,033,825 | 48,391 | Mar 09, 2022, 04:44 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 07, 2022 | Option Exercise | $130.09 | 13,392 | 1,742,165 | 81,125 | Mar 09, 2022, 04:40 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 07, 2022 | Option Exercise | $130.09 | 6,360 | 827,372 | 74,765 | Mar 09, 2022, 04:40 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 08, 2022 | Sale | $135.21 | 7,032 | 950,797 | 67,733 | Mar 09, 2022, 04:40 PM |
Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Mar 07, 2022 | Option Exercise | $130.09 | 19,856 | 2,583,067 | 77,138 | Mar 09, 2022, 04:36 PM |
Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Mar 07, 2022 | Option Exercise | $130.09 | 10,330 | 1,343,830 | 66,808 | Mar 09, 2022, 04:36 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 28, 2022 | Sale | $130.00 | 661 | 85,930 | 39,224 | Mar 02, 2022, 04:44 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 24, 2022 | Sale | $126.26 | 2,750 | 347,215 | 64,405 | Feb 28, 2022, 07:50 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 24, 2022 | Sale | $126.26 | 1,669 | 210,728 | 37,144 | Feb 28, 2022, 07:35 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Feb 23, 2022 | Option Exercise | $130.12 | 9,718 | 1,264,530 | 276,964 | Feb 25, 2022, 07:16 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 23, 2022 | Option Exercise | $130.13 | 1,339 | 174,247 | 39,219 | Feb 25, 2022, 07:13 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Feb 23, 2022 | Option Exercise | $130.13 | 313 | 40,731 | 26,727 | Feb 25, 2022, 07:10 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 23, 2022 | Option Exercise | $130.13 | 2,367 | 308,020 | 87,119 | Feb 25, 2022, 07:08 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 23, 2022 | Option Exercise | $130.13 | 1,574 | 204,831 | 67,647 | Feb 25, 2022, 07:05 PM |
Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Feb 23, 2022 | Option Exercise | $130.13 | 2,436 | 317,001 | 48,219 | Feb 25, 2022, 07:03 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Feb 23, 2022 | Option Exercise | $130.13 | 1,977 | 257,273 | 28,882 | Feb 25, 2022, 07:00 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Nov 29, 2021 | Option Exercise | $95.79 | 37,565 | 3,598,539 | 106,294 | Dec 01, 2021, 04:34 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Nov 29, 2021 | Sale | $156.81 | 37,565 | 5,890,576 | 105,994 | Dec 01, 2021, 04:34 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Jul 29, 2021 | Option Exercise | $95.79 | 9,493 | 909,382 | 289,727 | Jul 30, 2021, 04:16 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Jul 28, 2021 | Option Exercise | $95.79 | 139,751 | 13,387,447 | 424,178 | Jul 30, 2021, 04:16 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Jul 28, 2021 | Sale | $140.14 | 139,751 | 19,584,846 | 284,427 | Jul 30, 2021, 04:16 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Jul 29, 2021 | Sale | $140.87 | 9,493 | 1,337,251 | 284,427 | Jul 30, 2021, 04:16 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Jul 26, 2021 | Option Exercise | $95.79 | 5,813 | 556,856 | 290,240 | Jul 28, 2021, 04:21 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Jul 27, 2021 | Option Exercise | $95.79 | 32,788 | 3,140,926 | 317,215 | Jul 28, 2021, 04:21 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Jul 26, 2021 | Sale | $140.03 | 5,813 | 813,994 | 284,427 | Jul 28, 2021, 04:21 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Jul 27, 2021 | Sale | $140.01 | 32,788 | 4,590,550 | 284,427 | Jul 28, 2021, 04:21 PM |
WILENSKY GAIL R | Director | Jul 27, 2021 | Option Exercise | $59.39 | 12,222 | 725,926 | 23,956 | Jul 28, 2021, 04:18 PM |
WILENSKY GAIL R | Director | Jul 27, 2021 | Sale | $139.30 | 12,222 | 1,702,470 | 17,845 | Jul 28, 2021, 04:18 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | May 18, 2021 | Option Exercise | $136.60 | 5 | 683 | 26,859 | May 20, 2021, 04:26 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 09, 2021 | Option Exercise | $115.42 | 58,368 | 6,736,834 | 310,314 | Mar 11, 2021, 04:33 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 09, 2021 | Option Exercise | $115.42 | 25,887 | 2,987,877 | 284,427 | Mar 11, 2021, 04:33 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 09, 2021 | Option Exercise | $115.42 | 9,791 | 1,130,077 | 49,943 | Mar 11, 2021, 04:31 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 09, 2021 | Option Exercise | $115.42 | 4,217 | 486,726 | 45,726 | Mar 11, 2021, 04:31 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 10, 2021 | Sale | $120.47 | 5,574 | 671,500 | 40,152 | Mar 11, 2021, 04:31 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Mar 09, 2021 | Option Exercise | $115.42 | 1,884 | 217,451 | 27,485 | Mar 11, 2021, 04:29 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Mar 09, 2021 | Option Exercise | $115.42 | 684 | 78,947 | 26,802 | Mar 11, 2021, 04:29 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 09, 2021 | Option Exercise | $115.42 | 17,322 | 1,999,305 | 95,195 | Mar 11, 2021, 04:27 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 09, 2021 | Option Exercise | $115.42 | 6,403 | 739,034 | 88,792 | Mar 11, 2021, 04:27 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 09, 2021 | Option Exercise | $115.42 | 11,299 | 1,304,131 | 82,331 | Mar 11, 2021, 04:25 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 09, 2021 | Option Exercise | $115.42 | 5,066 | 584,718 | 77,265 | Mar 11, 2021, 04:25 PM |
Davis J. E. | EVP, General Diagnostics | Mar 09, 2021 | Option Exercise | $115.42 | 16,570 | 1,912,509 | 58,265 | Mar 11, 2021, 04:23 PM |
Davis J. E. | EVP, General Diagnostics | Mar 09, 2021 | Option Exercise | $115.42 | 8,334 | 961,910 | 49,931 | Mar 11, 2021, 04:23 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Mar 09, 2021 | Option Exercise | $115.42 | 13,181 | 1,521,351 | 36,394 | Mar 11, 2021, 04:20 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Mar 09, 2021 | Option Exercise | $115.42 | 6,165 | 711,564 | 30,250 | Mar 11, 2021, 04:20 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 25, 2021 | Sale | $115.49 | 801 | 92,507 | 40,152 | Mar 01, 2021, 04:29 PM |
Davis J. E. | EVP, General Diagnostics | Feb 24, 2021 | Option Exercise | $121.19 | 806 | 97,679 | 41,695 | Feb 25, 2021, 04:41 PM |
Davis J. E. | EVP, General Diagnostics | Feb 23, 2021 | Option Exercise | $121.15 | 1,250 | 151,438 | 42,501 | Feb 25, 2021, 04:41 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 24, 2021 | Option Exercise | $121.19 | 455 | 55,141 | 42,141 | Feb 25, 2021, 04:39 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 23, 2021 | Option Exercise | $121.15 | 693 | 83,957 | 42,596 | Feb 25, 2021, 04:39 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 24, 2021 | Sale | $116.95 | 1,188 | 138,937 | 41,703 | Feb 25, 2021, 04:39 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Feb 24, 2021 | Option Exercise | $121.19 | 103 | 12,483 | 25,601 | Feb 25, 2021, 04:36 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Feb 23, 2021 | Option Exercise | $121.15 | 159 | 19,263 | 25,704 | Feb 25, 2021, 04:36 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Feb 24, 2021 | Option Exercise | $121.19 | 611 | 74,047 | 23,213 | Feb 25, 2021, 04:34 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Feb 23, 2021 | Option Exercise | $121.15 | 1,017 | 123,210 | 23,824 | Feb 25, 2021, 04:34 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 24, 2021 | Option Exercise | $121.19 | 541 | 65,564 | 77,873 | Feb 25, 2021, 04:32 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 23, 2021 | Option Exercise | $121.15 | 830 | 100,555 | 78,414 | Feb 25, 2021, 04:32 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Feb 24, 2021 | Option Exercise | $121.19 | 3,319 | 402,230 | 251,946 | Feb 25, 2021, 04:31 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Feb 23, 2021 | Option Exercise | $121.15 | 4,033 | 488,598 | 255,265 | Feb 25, 2021, 04:31 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 24, 2021 | Option Exercise | $121.19 | 524 | 63,504 | 71,032 | Feb 25, 2021, 04:30 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 23, 2021 | Option Exercise | $121.15 | 796 | 96,435 | 71,556 | Feb 25, 2021, 04:30 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Jan 04, 2021 | Option Exercise | $119.00 | 2,640 | 314,160 | 19,896 | Jan 07, 2021, 08:18 AM |
GUINAN MARK | Executive Vice President & CFO | Dec 24, 2020 | Option Exercise | $66.51 | 81,756 | 5,437,592 | 155,335 | Dec 28, 2020, 04:27 PM |
GUINAN MARK | Executive Vice President & CFO | Dec 24, 2020 | Sale | $120.37 | 81,756 | 9,840,673 | 96,142 | Dec 28, 2020, 04:27 PM |
WILENSKY GAIL R | Director | Nov 24, 2020 | Option Exercise | $57.67 | 6,111 | 352,391 | 22,593 | Nov 27, 2020, 04:38 PM |
WILENSKY GAIL R | Director | Nov 24, 2020 | Sale | $126.02 | 6,111 | 770,120 | 16,482 | Nov 27, 2020, 04:38 PM |
STANZIONE DANIEL | Director | Nov 23, 2020 | Sale | $126.30 | 11,223 | 1,417,461 | 33,951 | Nov 24, 2020, 04:31 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Oct 21, 2020 | Option Exercise | $57.25 | 10,450 | 598,243 | 35,485 | Oct 23, 2020, 04:42 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Oct 21, 2020 | Sale | $125.00 | 10,450 | 1,306,250 | 29,785 | Oct 23, 2020, 04:42 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Oct 16, 2020 | Option Exercise | $66.51 | 291,997 | 19,420,721 | 529,744 | Oct 19, 2020, 04:17 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Oct 16, 2020 | Sale | $120.00 | 291,997 | 35,039,640 | 237,747 | Oct 19, 2020, 04:17 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Oct 14, 2020 | Option Exercise | $52.17 | 35,591 | 1,856,605 | 75,678 | Oct 15, 2020, 04:45 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Oct 14, 2020 | Sale | $119.00 | 35,591 | 4,235,329 | 40,087 | Oct 15, 2020, 04:45 PM |
Mendez Manuel O. | SVP & Chief Commercial Officer | Oct 06, 2020 | Option Exercise | $114.01 | 5,871 | 669,353 | 23,982 | Oct 07, 2020, 04:35 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sep 02, 2020 | Option Exercise | $66.51 | 58,392 | 3,883,652 | 126,803 | Sep 04, 2020, 04:18 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sep 02, 2020 | Sale | $110.60 | 58,392 | 6,458,343 | 72,187 | Sep 04, 2020, 04:18 PM |
GUINAN MARK | Executive Vice President & CFO | Jun 08, 2020 | Option Exercise | $71.17 | 72,596 | 5,166,657 | 146,175 | Jun 10, 2020, 04:33 PM |
GUINAN MARK | Executive Vice President & CFO | Jun 08, 2020 | Sale | $117.23 | 72,596 | 8,510,585 | 100,349 | Jun 10, 2020, 04:33 PM |
RING TIMOTHY M | Director | Jun 08, 2020 | Option Exercise | $58.50 | 11,730 | 686,209 | 32,235 | Jun 10, 2020, 04:31 PM |
RING TIMOTHY M | Director | Jun 08, 2020 | Sale | $116.60 | 11,730 | 1,367,718 | 20,505 | Jun 10, 2020, 04:31 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | May 18, 2020 | Option Exercise | $107.42 | 5 | 537 | 25,035 | May 20, 2020, 04:33 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Apr 27, 2020 | Option Exercise | $71.17 | 11,717 | 833,899 | 249,464 | Apr 28, 2020, 04:45 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Apr 27, 2020 | Sale | $112.01 | 11,717 | 1,312,433 | 237,747 | Apr 28, 2020, 04:45 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Apr 27, 2020 | Sale | $111.01 | 5,000 | 555,075 | 24,890 | Apr 28, 2020, 04:37 PM |
Davis J. E. | EVP, General Diagnostics | Mar 16, 2020 | Sale | $87.75 | 3,513 | 308,251 | 41,399 | Mar 17, 2020, 04:37 PM |
Davis J. E. | EVP, General Diagnostics | Mar 10, 2020 | Option Exercise | $106.46 | 7,359 | 783,439 | 45,445 | Mar 12, 2020, 05:02 PM |
Davis J. E. | EVP, General Diagnostics | Mar 10, 2020 | Option Exercise | $106.46 | 3,846 | 409,445 | 41,599 | Mar 12, 2020, 05:02 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 10, 2020 | Option Exercise | $106.46 | 4,349 | 462,995 | 44,436 | Mar 12, 2020, 05:00 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 10, 2020 | Option Exercise | $106.46 | 2,174 | 231,444 | 42,262 | Mar 12, 2020, 05:00 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 11, 2020 | Sale | $104.25 | 2,175 | 226,744 | 40,087 | Mar 12, 2020, 05:00 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 10, 2020 | Option Exercise | $106.46 | 7,693 | 818,997 | 77,449 | Mar 12, 2020, 04:58 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 10, 2020 | Option Exercise | $106.46 | 3,870 | 412,000 | 73,579 | Mar 12, 2020, 04:58 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 10, 2020 | Option Exercise | $106.46 | 5,018 | 534,216 | 73,429 | Mar 12, 2020, 04:57 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 10, 2020 | Option Exercise | $106.46 | 2,517 | 267,960 | 70,912 | Mar 12, 2020, 04:57 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 11, 2020 | Sale | $104.25 | 2,501 | 260,729 | 68,411 | Mar 12, 2020, 04:57 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 10, 2020 | Option Exercise | $106.46 | 25,085 | 2,670,549 | 251,645 | Mar 12, 2020, 04:55 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 10, 2020 | Option Exercise | $106.46 | 13,898 | 1,479,581 | 237,747 | Mar 12, 2020, 04:55 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 10, 2020 | Option Exercise | $71.17 | 100 | 7,117 | 237,847 | Mar 12, 2020, 04:55 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 10, 2020 | Sale | $112.19 | 100 | 11,219 | 237,747 | Mar 12, 2020, 04:55 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Mar 10, 2020 | Option Exercise | $106.46 | 837 | 89,107 | 25,253 | Mar 12, 2020, 04:54 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Mar 10, 2020 | Option Exercise | $106.46 | 277 | 29,489 | 24,977 | Mar 12, 2020, 04:54 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Mar 10, 2020 | Option Exercise | $106.46 | 5,018 | 534,216 | 29,907 | Mar 12, 2020, 04:52 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Mar 10, 2020 | Option Exercise | $106.46 | 2,517 | 267,960 | 27,390 | Mar 12, 2020, 04:52 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 06, 2020 | Option Exercise | $71.17 | 230,178 | 16,381,768 | 456,738 | Mar 10, 2020, 04:38 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 06, 2020 | Sale | $112.67 | 230,178 | 25,934,978 | 285,713 | Mar 10, 2020, 04:38 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 26, 2020 | Option Exercise | $112.90 | 668 | 75,417 | 40,777 | Feb 28, 2020, 05:53 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 27, 2020 | Sale | $109.02 | 690 | 75,224 | 40,087 | Feb 28, 2020, 05:53 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 26, 2020 | Sale | $111.09 | 321 | 35,660 | 41,445 | Feb 28, 2020, 05:53 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 26, 2020 | Option Exercise | $112.90 | 777 | 87,723 | 69,200 | Feb 28, 2020, 05:51 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 27, 2020 | Sale | $109.02 | 789 | 86,017 | 68,411 | Feb 28, 2020, 05:51 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 26, 2020 | Sale | $111.09 | 368 | 40,881 | 69,977 | Feb 28, 2020, 05:51 PM |
Davis J. E. | EVP, General Diagnostics | Feb 26, 2020 | Option Exercise | $112.90 | 1,187 | 134,012 | 39,205 | Feb 28, 2020, 05:50 PM |
Davis J. E. | EVP, General Diagnostics | Feb 27, 2020 | Sale | $109.02 | 1,100 | 119,922 | 38,105 | Feb 28, 2020, 05:50 PM |
Davis J. E. | EVP, General Diagnostics | Feb 26, 2020 | Sale | $111.09 | 510 | 56,656 | 40,392 | Feb 28, 2020, 05:50 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 26, 2020 | Option Exercise | $112.90 | 1,195 | 134,916 | 69,756 | Feb 27, 2020, 07:22 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Feb 26, 2020 | Option Exercise | $112.90 | 4,299 | 485,357 | 226,560 | Feb 27, 2020, 07:21 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Feb 26, 2020 | Option Exercise | $112.90 | 773 | 87,272 | 24,889 | Feb 27, 2020, 07:19 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Feb 26, 2020 | Option Exercise | $112.90 | 98 | 11,064 | 24,416 | Feb 27, 2020, 07:17 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Feb 25, 2020 | Option Exercise | $113.34 | 49 | 5,554 | 24,514 | Feb 26, 2020, 04:35 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Feb 24, 2020 | Option Exercise | $112.17 | 56 | 6,282 | 24,563 | Feb 26, 2020, 04:35 PM |
Davis J. E. | EVP, General Diagnostics | Feb 25, 2020 | Option Exercise | $113.34 | 552 | 62,564 | 40,902 | Feb 26, 2020, 04:34 PM |
Davis J. E. | EVP, General Diagnostics | Feb 24, 2020 | Option Exercise | $112.17 | 643 | 72,125 | 42,052 | Feb 26, 2020, 04:34 PM |
Davis J. E. | EVP, General Diagnostics | Feb 25, 2020 | Sale | $112.73 | 598 | 67,413 | 41,454 | Feb 26, 2020, 04:34 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 24, 2020 | Option Exercise | $112.17 | 382 | 42,849 | 42,073 | Feb 26, 2020, 04:33 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 25, 2020 | Option Exercise | $113.34 | 307 | 34,795 | 41,766 | Feb 26, 2020, 04:33 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Feb 25, 2020 | Option Exercise | $113.34 | 423 | 47,943 | 25,662 | Feb 26, 2020, 04:32 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Feb 24, 2020 | Option Exercise | $112.17 | 515 | 57,768 | 26,085 | Feb 26, 2020, 04:32 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Feb 25, 2020 | Option Exercise | $113.34 | 2,074 | 235,067 | 230,859 | Feb 26, 2020, 04:31 PM |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Feb 24, 2020 | Option Exercise | $112.17 | 2,404 | 269,657 | 232,933 | Feb 26, 2020, 04:31 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 24, 2020 | Option Exercise | $112.17 | 432 | 48,457 | 71,106 | Feb 26, 2020, 04:31 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 25, 2020 | Option Exercise | $113.34 | 356 | 40,349 | 70,345 | Feb 26, 2020, 04:31 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 25, 2020 | Sale | $112.73 | 405 | 45,656 | 70,701 | Feb 26, 2020, 04:31 PM |
Mendez Manuel O. | SVP & Chief Commercial Officer | Feb 24, 2020 | Option Exercise | $112.17 | 123 | 13,797 | 29,853 | Feb 26, 2020, 04:30 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 25, 2020 | Option Exercise | $113.34 | 565 | 64,037 | 70,951 | Feb 26, 2020, 04:29 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 24, 2020 | Option Exercise | $112.17 | 653 | 73,247 | 71,516 | Feb 26, 2020, 04:29 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Jan 02, 2020 | Option Exercise | $106.52 | 1,543 | 164,360 | 21,250 | Jan 06, 2020, 04:32 PM |
Davis J. E. | EVP, General Diagnostics | Jan 02, 2020 | Option Exercise | $68.64 | 143,546 | 9,853,318 | 180,080 | Jan 03, 2020, 12:00 AM |
Davis J. E. | EVP, General Diagnostics | Jan 02, 2020 | Sale | $105.57 | 143,537 | 15,153,865 | 121,822 | Jan 03, 2020, 12:00 AM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Nov 27, 2019 | Option Exercise | $55.07 | 44,556 | 2,453,565 | 84,014 | Dec 04, 2019, 04:32 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Nov 27, 2019 | Sale | $107.43 | 44,556 | 4,786,564 | 72,151 | Dec 04, 2019, 04:32 PM |
WILENSKY GAIL R | Director | Nov 26, 2019 | Option Exercise | $55.76 | 8,000 | 446,080 | 22,951 | Nov 27, 2019, 04:43 PM |
WILENSKY GAIL R | Director | Nov 26, 2019 | Sale | $107.17 | 8,000 | 857,352 | 14,951 | Nov 27, 2019, 04:43 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sep 17, 2019 | Option Exercise | $55.65 | 5,000 | 278,250 | 28,671 | Sep 19, 2019, 04:29 PM |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sep 17, 2019 | Sale | $106.00 | 5,000 | 530,000 | 23,732 | Sep 19, 2019, 04:29 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Jun 13, 2019 | Option Exercise | $52.17 | 244,565 | 12,757,733 | 457,614 | Jun 17, 2019, 04:36 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Jun 13, 2019 | Sale | $100.00 | 244,565 | 24,456,500 | 213,049 | Jun 17, 2019, 04:36 PM |
GUINAN MARK | Executive Vice President & CFO | Jun 13, 2019 | Option Exercise | $52.17 | 73,005 | 3,808,306 | 139,022 | Jun 17, 2019, 04:35 PM |
GUINAN MARK | Executive Vice President & CFO | Jun 13, 2019 | Sale | $100.00 | 73,005 | 7,300,500 | 66,017 | Jun 17, 2019, 04:35 PM |
Davis J. E. | EVP, General Diagnostics | Apr 24, 2019 | Option Exercise | $60.67 | 47,574 | 2,886,552 | 84,108 | Apr 26, 2019, 04:29 PM |
Davis J. E. | EVP, General Diagnostics | Apr 24, 2019 | Sale | $95.00 | 47,574 | 4,519,530 | 36,534 | Apr 26, 2019, 04:29 PM |
Davis J. E. | EVP, General Diagnostics | Apr 08, 2019 | Sale | $90.29 | 8,000 | 722,332 | 38,634 | Apr 10, 2019, 04:30 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Apr 04, 2019 | Option Exercise | $71.17 | 60,492 | 4,305,216 | 133,908 | Apr 08, 2019, 04:24 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Apr 04, 2019 | Sale | $90.59 | 66,382 | 6,013,739 | 73,416 | Apr 08, 2019, 04:24 PM |
Cunningham Everett | SVP, Commercial | Mar 01, 2018 | Option Exercise | $104.78 | 491 | 51,445 | 37,760 | Mar 25, 2019, 04:36 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Mar 01, 2019 | Option Exercise | $86.86 | 38,341 | 3,330,299 | 235,747 | Mar 05, 2019, 04:34 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Mar 01, 2019 | Option Exercise | $86.86 | 22,698 | 1,971,548 | 213,049 | Mar 05, 2019, 04:34 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 01, 2019 | Option Exercise | $86.86 | 6,647 | 577,358 | 46,100 | Mar 05, 2019, 04:32 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 01, 2019 | Option Exercise | $86.86 | 3,274 | 284,380 | 42,826 | Mar 05, 2019, 04:32 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 04, 2019 | Sale | $86.81 | 3,373 | 292,810 | 39,458 | Mar 05, 2019, 04:32 PM |
Klug Robert A | VP, Corporate Controller | Mar 01, 2019 | Option Exercise | $86.86 | 1,355 | 117,695 | 6,648 | Mar 05, 2019, 04:31 PM |
Klug Robert A | VP, Corporate Controller | Mar 01, 2019 | Option Exercise | $86.86 | 420 | 36,481 | 6,261 | Mar 05, 2019, 04:31 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 01, 2019 | Option Exercise | $86.86 | 10,736 | 932,529 | 71,305 | Mar 05, 2019, 04:30 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 01, 2019 | Option Exercise | $86.86 | 5,288 | 459,316 | 66,017 | Mar 05, 2019, 04:30 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 01, 2019 | Option Exercise | $86.86 | 7,669 | 666,129 | 77,193 | Mar 05, 2019, 04:29 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 01, 2019 | Option Exercise | $86.86 | 3,777 | 328,070 | 73,416 | Mar 05, 2019, 04:29 PM |
Davis J. E. | EVP, General Diagnostics | Mar 01, 2019 | Option Exercise | $86.86 | 10,225 | 888,144 | 50,321 | Mar 05, 2019, 04:27 PM |
Davis J. E. | EVP, General Diagnostics | Mar 01, 2019 | Option Exercise | $86.86 | 5,839 | 507,176 | 44,534 | Mar 05, 2019, 04:27 PM |
Cunningham Everett | SVP, Commercial | Mar 01, 2019 | Option Exercise | $86.86 | 7,669 | 666,129 | 45,928 | Mar 05, 2019, 04:26 PM |
Cunningham Everett | SVP, Commercial | Mar 01, 2019 | Option Exercise | $86.86 | 3,777 | 328,070 | 42,151 | Mar 05, 2019, 04:26 PM |
Cunningham Everett | SVP, Commercial | Mar 04, 2019 | Sale | $86.81 | 3,892 | 337,865 | 38,311 | Mar 05, 2019, 04:26 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Feb 26, 2019 | Option Exercise | $87.84 | 6,676 | 586,420 | 197,406 | Feb 28, 2019, 05:32 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 26, 2019 | Option Exercise | $87.84 | 907 | 79,671 | 40,865 | Feb 28, 2019, 05:24 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 27, 2019 | Sale | $86.51 | 1,048 | 90,662 | 39,453 | Feb 28, 2019, 05:24 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 26, 2019 | Sale | $87.06 | 364 | 31,690 | 40,501 | Feb 28, 2019, 05:24 PM |
Klug Robert A | VP, Corporate Controller | Feb 26, 2019 | Option Exercise | $87.84 | 142 | 12,473 | 5,293 | Feb 28, 2019, 05:22 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 26, 2019 | Option Exercise | $87.84 | 1,556 | 136,679 | 60,569 | Feb 28, 2019, 05:21 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 26, 2019 | Option Exercise | $87.84 | 1,066 | 93,637 | 69,524 | Feb 28, 2019, 05:19 PM |
Davis J. E. | EVP, General Diagnostics | Feb 26, 2019 | Option Exercise | $87.84 | 1,432 | 125,787 | 40,096 | Feb 28, 2019, 05:15 PM |
Cunningham Everett | SVP, Commercial | Feb 26, 2019 | Option Exercise | $87.84 | 1,112 | 97,678 | 39,755 | Feb 28, 2019, 05:11 PM |
Cunningham Everett | SVP, Commercial | Feb 27, 2019 | Sale | $86.51 | 1,144 | 98,967 | 38,259 | Feb 28, 2019, 05:11 PM |
Cunningham Everett | SVP, Commercial | Feb 26, 2019 | Sale | $87.06 | 352 | 30,645 | 39,403 | Feb 28, 2019, 05:11 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Feb 25, 2019 | Option Exercise | $88.24 | 2,318 | 204,540 | 204,082 | Feb 27, 2019, 06:35 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 25, 2019 | Option Exercise | $88.24 | 315 | 27,796 | 42,108 | Feb 27, 2019, 06:34 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 25, 2019 | Sale | $88.23 | 336 | 29,645 | 41,772 | Feb 27, 2019, 06:34 PM |
Klug Robert A | VP, Corporate Controller | Feb 25, 2019 | Option Exercise | $88.24 | 52 | 4,588 | 5,435 | Feb 27, 2019, 06:32 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 25, 2019 | Option Exercise | $88.24 | 660 | 58,238 | 62,125 | Feb 27, 2019, 06:29 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Feb 25, 2019 | Option Exercise | $88.24 | 363 | 32,031 | 22,793 | Feb 27, 2019, 06:27 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 25, 2019 | Option Exercise | $88.24 | 363 | 32,031 | 70,590 | Feb 27, 2019, 06:25 PM |
Davis J. E. | EVP, General Diagnostics | Feb 25, 2019 | Option Exercise | $88.24 | 547 | 48,267 | 41,528 | Feb 27, 2019, 06:22 PM |
Cunningham Everett | SVP, Commercial | Feb 25, 2019 | Option Exercise | $88.24 | 431 | 38,031 | 41,193 | Feb 27, 2019, 06:19 PM |
Cunningham Everett | SVP, Commercial | Feb 25, 2019 | Sale | $88.23 | 326 | 28,763 | 40,867 | Feb 27, 2019, 06:19 PM |
WILENSKY GAIL R | Director | Feb 22, 2019 | Option Exercise | $51.55 | 8,000 | 412,400 | 34,604 | Feb 25, 2019, 08:08 PM |
WILENSKY GAIL R | Director | Feb 22, 2019 | Sale | $87.78 | 8,000 | 702,216 | 26,604 | Feb 25, 2019, 08:08 PM |
Klug Robert A | VP, Corporate Controller | Feb 22, 2019 | Option Exercise | $88.39 | 50 | 4,419 | 5,487 | Feb 25, 2019, 08:06 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Feb 22, 2019 | Option Exercise | $88.39 | 2,215 | 195,784 | 206,400 | Feb 25, 2019, 08:04 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 22, 2019 | Option Exercise | $88.39 | 291 | 25,721 | 42,423 | Feb 25, 2019, 08:01 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 22, 2019 | Option Exercise | $88.39 | 610 | 53,918 | 62,785 | Feb 25, 2019, 07:58 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Feb 22, 2019 | Option Exercise | $88.39 | 392 | 34,649 | 23,156 | Feb 25, 2019, 07:55 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 22, 2019 | Option Exercise | $88.39 | 336 | 29,699 | 70,953 | Feb 25, 2019, 07:53 PM |
Davis J. E. | EVP, General Diagnostics | Feb 22, 2019 | Option Exercise | $88.39 | 506 | 44,725 | 42,075 | Feb 25, 2019, 07:40 PM |
Cunningham Everett | SVP, Commercial | Feb 22, 2019 | Option Exercise | $88.39 | 398 | 35,179 | 41,624 | Feb 25, 2019, 07:36 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Dec 31, 2018 | Option Exercise | $82.27 | 1,767 | 145,371 | 19,507 | Jan 03, 2019, 12:00 AM |
Klug Robert A | VP, Corporate Controller | Oct 12, 2018 | Option Exercise | $100.51 | 8 | 804 | 4,972 | Oct 16, 2018, 04:33 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jul 10, 2018 | Option Exercise | $57.60 | 30,780 | 1,773,082 | 70,551 | Jul 12, 2018, 04:53 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jul 10, 2018 | Sale | $113.07 | 30,780 | 3,480,141 | 39,791 | Jul 12, 2018, 04:53 PM |
Cunningham Everett | SVP, Commercial | Jul 10, 2018 | Option Exercise | $71.17 | 40,328 | 2,870,144 | 78,589 | Jul 12, 2018, 04:52 PM |
Cunningham Everett | SVP, Commercial | Jul 10, 2018 | Sale | $112.00 | 40,328 | 4,516,736 | 38,261 | Jul 12, 2018, 04:52 PM |
Cunningham Everett | SVP, Commercial | Jul 02, 2018 | Option Exercise | $61.44 | 60,222 | 3,699,903 | 84,844 | Jul 05, 2018, 04:38 PM |
Cunningham Everett | SVP, Commercial | Jul 02, 2018 | Sale | $109.67 | 68,069 | 7,465,043 | 51,499 | Jul 05, 2018, 04:38 PM |
LEIDEN JEFFREY M | Director | May 29, 2018 | Sale | $105.61 | 1,644 | 173,623 | 6,000 | May 30, 2018, 04:38 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | May 25, 2018 | Option Exercise | $56.12 | 168,490 | 9,455,659 | 359,559 | May 29, 2018, 04:39 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | May 25, 2018 | Sale | $107.00 | 168,490 | 18,028,430 | 191,069 | May 29, 2018, 04:39 PM |
GUINAN MARK | Executive Vice President & CFO | May 25, 2018 | Option Exercise | $58.37 | 61,533 | 3,591,374 | 119,733 | May 29, 2018, 04:37 PM |
GUINAN MARK | Executive Vice President & CFO | May 25, 2018 | Sale | $105.71 | 61,533 | 6,504,682 | 83,160 | May 29, 2018, 04:37 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Mar 08, 2018 | Option Exercise | $66.51 | 38,928 | 2,589,101 | 115,426 | Mar 12, 2018, 04:33 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Mar 08, 2018 | Sale | $104.20 | 83,669 | 8,717,937 | 97,389 | Mar 12, 2018, 04:33 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 02, 2018 | Option Exercise | $101.00 | 13,137 | 1,326,837 | 64,671 | Mar 06, 2018, 07:52 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 02, 2018 | Option Exercise | $101.00 | 6,471 | 653,571 | 58,200 | Mar 06, 2018, 07:52 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 27, 2018 | Option Exercise | $101.43 | 779 | 79,014 | 51,534 | Mar 06, 2018, 07:47 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 26, 2018 | Option Exercise | $101.43 | 1,454 | 147,479 | 52,313 | Mar 06, 2018, 07:45 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 23, 2018 | Option Exercise | $102.69 | 592 | 60,792 | 53,767 | Mar 06, 2018, 07:45 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Mar 02, 2018 | Option Exercise | $101.00 | 43,789 | 4,422,689 | 214,497 | Mar 06, 2018, 07:43 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Mar 02, 2018 | Option Exercise | $101.00 | 23,428 | 2,366,228 | 191,069 | Mar 06, 2018, 07:43 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 02, 2018 | Option Exercise | $101.00 | 8,134 | 821,534 | 47,900 | Mar 06, 2018, 07:41 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 02, 2018 | Option Exercise | $101.00 | 4,006 | 404,606 | 43,899 | Mar 06, 2018, 07:41 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 05, 2018 | Sale | $101.00 | 4,128 | 416,928 | 39,771 | Mar 06, 2018, 07:41 PM |
Klug Robert A | VP, Corporate Controller | Mar 02, 2018 | Option Exercise | $101.00 | 1,365 | 137,865 | 5,206 | Mar 06, 2018, 07:40 PM |
Klug Robert A | VP, Corporate Controller | Mar 02, 2018 | Option Exercise | $101.00 | 429 | 43,329 | 4,803 | Mar 06, 2018, 07:40 PM |
Davis J. E. | EVP, General Diagnostics | Mar 02, 2018 | Option Exercise | $101.00 | 11,886 | 1,200,486 | 48,909 | Mar 06, 2018, 07:39 PM |
Davis J. E. | EVP, General Diagnostics | Mar 02, 2018 | Option Exercise | $101.00 | 6,764 | 683,164 | 42,189 | Mar 06, 2018, 07:39 PM |
Davis J. E. | EVP, General Diagnostics | Mar 05, 2018 | Sale | $101.00 | 5,122 | 517,322 | 37,067 | Mar 06, 2018, 07:39 PM |
Cunningham Everett | SVP, Commercial | Mar 02, 2018 | Option Exercise | $101.00 | 10,949 | 1,105,849 | 51,266 | Mar 06, 2018, 07:38 PM |
Cunningham Everett | SVP, Commercial | Mar 02, 2018 | Option Exercise | $101.00 | 5,393 | 544,693 | 45,916 | Mar 06, 2018, 07:38 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Mar 02, 2018 | Option Exercise | $101.00 | 10,949 | 1,105,849 | 81,891 | Mar 06, 2018, 07:37 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Mar 02, 2018 | Option Exercise | $101.00 | 5,393 | 544,693 | 76,498 | Mar 06, 2018, 07:37 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 02, 2018 | Option Exercise | $101.00 | 10,949 | 1,105,849 | 78,890 | Mar 06, 2018, 07:36 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 02, 2018 | Option Exercise | $101.00 | 5,393 | 544,693 | 73,497 | Mar 06, 2018, 07:36 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 05, 2018 | Sale | $101.00 | 5,556 | 561,156 | 67,941 | Mar 06, 2018, 07:36 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Feb 27, 2018 | Option Exercise | $101.43 | 3,017 | 306,014 | 170,708 | Mar 01, 2018, 05:11 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 27, 2018 | Option Exercise | $101.43 | 482 | 48,889 | 41,189 | Mar 01, 2018, 05:08 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 27, 2018 | Sale | $104.10 | 927 | 96,501 | 40,262 | Mar 01, 2018, 05:08 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 28, 2018 | Sale | $104.99 | 496 | 52,075 | 39,766 | Mar 01, 2018, 05:08 PM |
Klug Robert A | VP, Corporate Controller | Feb 27, 2018 | Option Exercise | $101.43 | 62 | 6,289 | 3,841 | Mar 01, 2018, 05:05 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 27, 2018 | Option Exercise | $101.43 | 585 | 59,337 | 52,090 | Mar 01, 2018, 05:03 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 27, 2018 | Option Exercise | $101.43 | 556 | 56,395 | 69,761 | Mar 01, 2018, 04:58 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 28, 2018 | Sale | $104.99 | 572 | 60,054 | 67,941 | Mar 01, 2018, 04:58 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 27, 2018 | Sale | $104.10 | 1,248 | 129,917 | 68,513 | Mar 01, 2018, 04:58 PM |
Davis J. E. | EVP, General Diagnostics | Feb 27, 2018 | Option Exercise | $101.43 | 856 | 86,824 | 38,821 | Mar 01, 2018, 04:56 PM |
Davis J. E. | EVP, General Diagnostics | Feb 28, 2018 | Sale | $104.99 | 648 | 68,034 | 37,023 | Mar 01, 2018, 04:56 PM |
Davis J. E. | EVP, General Diagnostics | Feb 27, 2018 | Sale | $104.10 | 1,150 | 119,715 | 37,671 | Mar 01, 2018, 04:56 PM |
Cunningham Everett | SVP, Commercial | Feb 27, 2018 | Option Exercise | $101.43 | 556 | 56,395 | 40,317 | Mar 01, 2018, 04:36 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Feb 27, 2018 | Option Exercise | $101.43 | 556 | 56,395 | 70,942 | Mar 01, 2018, 04:32 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 26, 2018 | Option Exercise | $101.43 | 900 | 91,287 | 41,671 | Feb 27, 2018, 04:53 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 23, 2018 | Option Exercise | $102.69 | 317 | 32,553 | 42,571 | Feb 27, 2018, 04:53 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Feb 26, 2018 | Option Exercise | $101.43 | 5,263 | 533,826 | 173,725 | Feb 27, 2018, 04:41 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Feb 23, 2018 | Option Exercise | $102.69 | 2,094 | 215,033 | 178,988 | Feb 27, 2018, 04:41 PM |
Klug Robert A | VP, Corporate Controller | Feb 26, 2018 | Option Exercise | $101.43 | 77 | 7,810 | 5,060 | Feb 27, 2018, 04:40 PM |
Klug Robert A | VP, Corporate Controller | Feb 23, 2018 | Option Exercise | $102.69 | 43 | 4,416 | 5,137 | Feb 27, 2018, 04:40 PM |
Klug Robert A | VP, Corporate Controller | Feb 26, 2018 | Sale | $103.66 | 1,157 | 119,932 | 3,903 | Feb 27, 2018, 04:40 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 26, 2018 | Option Exercise | $101.43 | 1,092 | 110,762 | 52,675 | Feb 27, 2018, 04:39 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 23, 2018 | Option Exercise | $102.69 | 592 | 60,792 | 53,767 | Feb 27, 2018, 04:39 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 26, 2018 | Option Exercise | $101.43 | 1,212 | 122,933 | 70,714 | Feb 27, 2018, 04:38 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 23, 2018 | Option Exercise | $102.69 | 386 | 39,638 | 71,926 | Feb 27, 2018, 04:38 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 26, 2018 | Sale | $102.74 | 397 | 40,788 | 70,317 | Feb 27, 2018, 04:38 PM |
Davis J. E. | EVP, General Diagnostics | Feb 26, 2018 | Option Exercise | $101.43 | 1,520 | 154,174 | 40,171 | Feb 27, 2018, 04:37 PM |
Davis J. E. | EVP, General Diagnostics | Feb 23, 2018 | Option Exercise | $102.69 | 654 | 67,159 | 41,691 | Feb 27, 2018, 04:37 PM |
Davis J. E. | EVP, General Diagnostics | Feb 26, 2018 | Sale | $102.74 | 494 | 50,754 | 39,677 | Feb 27, 2018, 04:37 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Feb 26, 2018 | Option Exercise | $101.43 | 1,212 | 122,933 | 71,498 | Feb 27, 2018, 04:35 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Feb 23, 2018 | Option Exercise | $102.69 | 387 | 39,741 | 72,710 | Feb 27, 2018, 04:35 PM |
Cunningham Everett | SVP, Commercial | Feb 26, 2018 | Option Exercise | $101.43 | 1,212 | 122,933 | 40,873 | Feb 27, 2018, 04:35 PM |
Cunningham Everett | SVP, Commercial | Feb 23, 2018 | Option Exercise | $102.69 | 387 | 39,741 | 42,085 | Feb 27, 2018, 04:35 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Feb 23, 2018 | Option Exercise | $102.69 | 387 | 39,741 | 21,274 | Feb 27, 2018, 04:32 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Jan 29, 2018 | Option Exercise | $58.17 | 106,840 | 6,215,417 | 272,956 | Jan 31, 2018, 04:33 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Jan 29, 2018 | Sale | $107.00 | 106,840 | 11,431,880 | 166,116 | Jan 31, 2018, 04:33 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Jan 24, 2018 | Option Exercise | $52.17 | 21,294 | 1,110,802 | 90,709 | Jan 26, 2018, 04:43 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Jan 24, 2018 | Sale | $104.00 | 21,294 | 2,214,576 | 69,415 | Jan 26, 2018, 04:43 PM |
Davis J. E. | EVP, General Diagnostics | Jan 02, 2018 | Option Exercise | $52.17 | 63,880 | 3,332,300 | 101,423 | Jan 04, 2018, 04:34 PM |
Davis J. E. | EVP, General Diagnostics | Jan 02, 2018 | Sale | $98.68 | 63,880 | 6,303,359 | 38,053 | Jan 04, 2018, 04:34 PM |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Jan 02, 2018 | Option Exercise | $99.12 | 2,256 | 223,615 | 18,281 | Jan 04, 2018, 04:33 PM |
Klug Robert A | VP, Corporate Controller | Oct 13, 2017 | Option Exercise | $91.10 | 9 | 820 | 4,515 | Oct 17, 2017, 04:36 PM |
STANZIONE DANIEL | Director | Sep 11, 2017 | Option Exercise | $57.15 | 40,900 | 2,337,327 | 75,575 | Sep 13, 2017, 06:20 PM |
STANZIONE DANIEL | Director | Sep 11, 2017 | Sale | $108.07 | 40,900 | 4,419,940 | 34,675 | Sep 13, 2017, 06:20 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Sep 12, 2017 | Option Exercise | $58.17 | 5,302 | 308,444 | 171,418 | Sep 13, 2017, 06:18 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Sep 11, 2017 | Option Exercise | $58.17 | 53,933 | 3,137,552 | 220,049 | Sep 13, 2017, 06:18 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Sep 12, 2017 | Sale | $108.12 | 5,302 | 573,236 | 166,116 | Sep 13, 2017, 06:18 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Sep 11, 2017 | Sale | $108.16 | 53,933 | 5,833,609 | 166,116 | Sep 13, 2017, 06:18 PM |
STANZIONE DANIEL | Director | Sep 05, 2017 | Option Exercise | $57.14 | 3,803 | 217,305 | 38,478 | Sep 07, 2017, 04:43 PM |
STANZIONE DANIEL | Director | Sep 05, 2017 | Sale | $108.01 | 3,803 | 410,762 | 34,675 | Sep 07, 2017, 04:43 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Sep 05, 2017 | Option Exercise | $58.17 | 2,525 | 146,892 | 168,413 | Sep 07, 2017, 04:40 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Sep 05, 2017 | Sale | $108.03 | 2,525 | 272,768 | 166,116 | Sep 07, 2017, 04:40 PM |
LEIDEN JEFFREY M | Director | Aug 04, 2017 | Sale | $106.66 | 296 | 31,571 | 6,000 | Aug 08, 2017, 04:27 PM |
LEIDEN JEFFREY M | Director | Jul 27, 2017 | Sale | $108.73 | 1,304 | 141,783 | 6,296 | Jul 31, 2017, 04:42 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Jun 19, 2017 | Option Exercise | $53.95 | 106,900 | 5,766,897 | 180,083 | Jun 21, 2017, 04:28 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Jun 19, 2017 | Sale | $107.55 | 106,900 | 11,497,134 | 166,739 | Jun 21, 2017, 04:28 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Jun 19, 2017 | Option Exercise | $57.40 | 59,762 | 3,430,459 | 129,177 | Jun 21, 2017, 04:27 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Jun 19, 2017 | Sale | $107.55 | 59,762 | 6,427,118 | 120,325 | Jun 21, 2017, 04:27 PM |
BRITELL JENNE K | Director | Apr 24, 2017 | Option Exercise | $57.67 | 6,111 | 352,421 | 25,996 | Apr 26, 2017, 04:34 PM |
BRITELL JENNE K | Director | Apr 24, 2017 | Sale | $104.03 | 6,111 | 635,727 | 19,903 | Apr 26, 2017, 04:34 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Apr 20, 2017 | Option Exercise | $56.78 | 29,513 | 1,675,743 | 68,822 | Apr 24, 2017, 04:18 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Apr 20, 2017 | Sale | $100.00 | 29,513 | 2,951,300 | 40,327 | Apr 24, 2017, 04:18 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 16, 2017 | Option Exercise | $55.65 | 13,987 | 778,377 | 54,309 | Mar 20, 2017, 04:37 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 16, 2017 | Sale | $100.00 | 13,987 | 1,398,700 | 40,322 | Mar 20, 2017, 04:37 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 03, 2017 | Sale | $98.29 | 4,478 | 440,143 | 40,322 | Mar 06, 2017, 04:40 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 02, 2017 | Option Exercise | $98.12 | 12,520 | 1,228,462 | 87,809 | Mar 06, 2017, 04:39 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 02, 2017 | Option Exercise | $98.12 | 6,492 | 636,995 | 81,317 | Mar 06, 2017, 04:39 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 03, 2017 | Sale | $98.29 | 6,028 | 592,492 | 74,155 | Mar 06, 2017, 04:39 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 02, 2017 | Sale | $98.25 | 1,134 | 111,416 | 80,183 | Mar 06, 2017, 04:39 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 02, 2017 | Option Exercise | $98.12 | 9,302 | 912,712 | 49,619 | Mar 03, 2017, 05:15 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 02, 2017 | Option Exercise | $98.12 | 4,824 | 473,331 | 44,800 | Mar 03, 2017, 05:15 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 01, 2017 | Sale | $97.77 | 470 | 45,952 | 40,317 | Mar 03, 2017, 05:15 PM |
Klug Robert A | VP, Corporate Controller | Mar 02, 2017 | Option Exercise | $98.12 | 1,217 | 119,412 | 4,722 | Mar 03, 2017, 05:13 PM |
Klug Robert A | VP, Corporate Controller | Mar 02, 2017 | Option Exercise | $98.12 | 419 | 41,112 | 4,330 | Mar 03, 2017, 05:13 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 02, 2017 | Option Exercise | $98.12 | 14,309 | 1,403,999 | 57,337 | Mar 03, 2017, 05:10 PM |
GUINAN MARK | Executive Vice President & CFO | Mar 02, 2017 | Option Exercise | $98.12 | 7,420 | 728,050 | 49,917 | Mar 03, 2017, 05:10 PM |
Davis J. E. | EVP, General Diagnostics | Mar 02, 2017 | Option Exercise | $98.12 | 12,520 | 1,228,462 | 44,918 | Mar 03, 2017, 05:08 PM |
Davis J. E. | EVP, General Diagnostics | Mar 02, 2017 | Option Exercise | $98.12 | 7,421 | 728,149 | 37,543 | Mar 03, 2017, 05:08 PM |
Cunningham Everett | SVP, Commercial | Mar 02, 2017 | Option Exercise | $98.12 | 12,520 | 1,228,462 | 45,498 | Mar 03, 2017, 05:07 PM |
Cunningham Everett | SVP, Commercial | Mar 02, 2017 | Option Exercise | $98.12 | 6,492 | 636,995 | 39,052 | Mar 03, 2017, 05:07 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Mar 02, 2017 | Option Exercise | $98.12 | 12,520 | 1,228,462 | 79,585 | Mar 03, 2017, 05:01 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Mar 02, 2017 | Option Exercise | $98.12 | 6,402 | 628,164 | 73,183 | Mar 03, 2017, 05:01 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Mar 02, 2017 | Option Exercise | $98.12 | 47,934 | 4,703,284 | 192,682 | Mar 03, 2017, 05:00 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Mar 02, 2017 | Option Exercise | $98.12 | 26,891 | 2,638,545 | 165,888 | Mar 03, 2017, 05:00 PM |
Klug Robert A | VP, Corporate Controller | Feb 28, 2017 | Option Exercise | $96.42 | 69 | 6,653 | 3,505 | Mar 02, 2017, 04:50 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Feb 28, 2017 | Option Exercise | $96.42 | 3,163 | 304,976 | 144,748 | Mar 02, 2017, 04:47 PM |
Cunningham Everett | SVP, Commercial | Feb 28, 2017 | Option Exercise | $96.42 | 585 | 56,406 | 32,978 | Mar 02, 2017, 04:46 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 28, 2017 | Option Exercise | $96.42 | 507 | 48,885 | 40,787 | Mar 02, 2017, 04:43 PM |
Davis J. E. | EVP, General Diagnostics | Feb 28, 2017 | Option Exercise | $96.42 | 675 | 65,083 | 32,398 | Mar 02, 2017, 04:42 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Feb 28, 2017 | Option Exercise | $96.42 | 420 | 40,496 | 67,065 | Mar 02, 2017, 04:41 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Feb 24, 2017 | Option Exercise | $95.68 | 2,759 | 263,981 | 147,911 | Feb 28, 2017, 04:50 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 24, 2017 | Option Exercise | $95.68 | 474 | 45,352 | 41,734 | Feb 28, 2017, 04:49 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 27, 2017 | Sale | $97.39 | 440 | 42,852 | 41,294 | Feb 28, 2017, 04:49 PM |
Davis J. E. | EVP, General Diagnostics | Feb 24, 2017 | Option Exercise | $95.68 | 600 | 57,408 | 33,073 | Feb 28, 2017, 04:48 PM |
Klug Robert A | VP, Corporate Controller | Feb 24, 2017 | Option Exercise | $95.68 | 43 | 4,114 | 3,574 | Feb 28, 2017, 04:47 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 24, 2017 | Option Exercise | $95.68 | 585 | 55,973 | 43,653 | Feb 28, 2017, 04:45 PM |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 24, 2017 | Option Exercise | $95.68 | 638 | 61,044 | 75,874 | Feb 28, 2017, 04:44 PM |
Cunningham Everett | SVP, Commercial | Feb 24, 2017 | Option Exercise | $95.68 | 638 | 61,044 | 33,563 | Feb 28, 2017, 04:42 PM |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | Feb 24, 2017 | Option Exercise | $95.68 | 459 | 43,917 | 67,485 | Feb 28, 2017, 04:41 PM |
ZIEGLER JOHN B | Director | Feb 22, 2017 | Sale | $95.51 | 2,000 | 191,016 | 16,557 | Feb 24, 2017, 04:32 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Feb 15, 2017 | Sale | $94.65 | 1,615 | 152,858 | 73,380 | Feb 17, 2017, 04:35 PM |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Feb 13, 2017 | Option Exercise | $93.85 | 5,686 | 533,631 | 135,011 | Feb 15, 2017, 04:45 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 13, 2017 | Option Exercise | $93.85 | 1,293 | 121,348 | 40,693 | Feb 15, 2017, 04:43 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 13, 2017 | Sale | $93.76 | 1,200 | 112,512 | 39,493 | Feb 15, 2017, 04:43 PM |
Klug Robert A | VP, Corporate Controller | Feb 13, 2017 | Option Exercise | $93.96 | 126 | 11,839 | 3,053 | Feb 15, 2017, 04:41 PM |
GUINAN MARK | Executive Vice President & CFO | Feb 13, 2017 | Option Exercise | $93.85 | 1,451 | 136,176 | 39,436 | Feb 15, 2017, 04:40 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Feb 13, 2017 | Option Exercise | $93.85 | 1,740 | 163,299 | 74,995 | Feb 15, 2017, 04:38 PM |
Davis J. E. | EVP, General Diagnostics | Feb 13, 2017 | Option Exercise | $93.85 | 1,529 | 143,497 | 29,079 | Feb 15, 2017, 04:36 PM |
Cunningham Everett | SVP, Commercial | Feb 13, 2017 | Option Exercise | $93.85 | 1,278 | 119,940 | 31,069 | Feb 15, 2017, 04:34 PM |
Cohen Jon R | SVP, Diagnostic Solutions | Feb 13, 2017 | Option Exercise | $93.85 | 1,274 | 119,565 | 64,812 | Feb 15, 2017, 04:33 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 02, 2017 | Option Exercise | $52.68 | 45,000 | 2,370,750 | 71,918 | Feb 06, 2017, 04:36 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 02, 2017 | Sale | $92.39 | 45,000 | 4,157,595 | 41,986 | Feb 06, 2017, 04:36 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Jan 30, 2017 | Option Exercise | $54.01 | 80,000 | 4,321,172 | 119,321 | Feb 01, 2017, 08:23 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Jan 30, 2017 | Sale | $90.58 | 80,000 | 7,246,362 | 88,221 | Feb 01, 2017, 08:23 PM |
PFEIFFER GARY M | Director | Nov 15, 2016 | Option Exercise | $56.41 | 34,333 | 1,936,796 | 30,008 | Nov 17, 2016, 05:25 PM |
PFEIFFER GARY M | Director | Nov 15, 2016 | Sale | $85.09 | 42,643 | 3,628,425 | 22,008 | Nov 17, 2016, 05:25 PM |
Klug Robert A | VP, Corporate Controller | Aug 22, 2016 | Option Exercise | $84.57 | 84 | 7,104 | 2,888 | Aug 24, 2016, 04:47 PM |
GUINAN MARK | Senior Vice President & CFO | Aug 22, 2016 | Option Exercise | $84.57 | 8,440 | 713,771 | 47,550 | Aug 24, 2016, 04:46 PM |
Klug Robert A | VP, Corporate Controller | Aug 18, 2016 | Option Exercise | $84.89 | 11 | 934 | 2,972 | Aug 22, 2016, 04:54 PM |
BRITELL JENNE K | Director | Aug 19, 2016 | Option Exercise | $55.76 | 4,000 | 223,040 | 23,885 | Aug 22, 2016, 04:53 PM |
BRITELL JENNE K | Director | Aug 19, 2016 | Sale | $84.76 | 4,000 | 339,052 | 19,885 | Aug 22, 2016, 04:53 PM |
BRITELL JENNE K | Director | Aug 10, 2016 | Option Exercise | $55.76 | 4,000 | 223,040 | 23,876 | Aug 11, 2016, 04:32 PM |
BRITELL JENNE K | Director | Aug 10, 2016 | Sale | $85.20 | 4,000 | 340,808 | 19,885 | Aug 11, 2016, 04:32 PM |
LEIDEN JEFFREY M | Director | Aug 03, 2016 | Option Exercise | $69.52 | 6,641 | 461,696 | 7,774 | Aug 04, 2016, 04:46 PM |
LEIDEN JEFFREY M | Director | Aug 03, 2016 | Sale | $85.62 | 6,345 | 543,262 | 6,827 | Aug 04, 2016, 04:46 PM |
ZIEGLER JOHN B | Director | Jul 25, 2016 | Sale | $84.36 | 1,000 | 84,359 | 18,557 | Jul 27, 2016, 04:32 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | May 27, 2016 | Option Exercise | $56.24 | 47,334 | 2,661,828 | 124,069 | Jun 01, 2016, 04:39 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | May 27, 2016 | Sale | $77.27 | 47,334 | 3,657,309 | 100,402 | Jun 01, 2016, 04:39 PM |
Davis J. E. | SVP, Regional Businesses | May 23, 2016 | Option Exercise | $76.30 | 1,907 | 145,504 | 30,077 | May 25, 2016, 04:27 PM |
BRITELL JENNE K | Director | May 12, 2016 | Option Exercise | $51.55 | 8,000 | 412,400 | 19,655 | May 16, 2016, 04:25 PM |
BRITELL JENNE K | Director | May 12, 2016 | Sale | $75.68 | 8,000 | 605,456 | 11,655 | May 16, 2016, 04:25 PM |
Cunningham Everett | SVP, Commercial | May 09, 2016 | Option Exercise | $59.66 | 56,312 | 3,359,672 | 74,949 | May 11, 2016, 04:21 PM |
Cunningham Everett | SVP, Commercial | May 09, 2016 | Sale | $76.26 | 56,312 | 4,294,396 | 31,889 | May 11, 2016, 04:21 PM |
Cunningham Everett | SVP, Commercial | May 06, 2016 | Option Exercise | $54.84 | 50,447 | 2,766,684 | 74,286 | May 09, 2016, 04:19 PM |
Cunningham Everett | SVP, Commercial | May 06, 2016 | Sale | $76.00 | 50,447 | 3,833,972 | 31,889 | May 09, 2016, 04:19 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Apr 25, 2016 | Option Exercise | $51.20 | 23,667 | 1,211,750 | 106,285 | Apr 27, 2016, 04:19 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Apr 25, 2016 | Sale | $74.45 | 29,550 | 2,199,916 | 82,618 | Apr 27, 2016, 04:19 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 01, 2016 | Option Exercise | $66.51 | 906 | 60,258 | 41,918 | Mar 14, 2016, 04:26 PM |
Cohen Jon R | SVP, Diagnostic Solutions | Mar 01, 2016 | Option Exercise | $67.01 | 2,684 | 179,855 | 68,409 | Mar 03, 2016, 04:26 PM |
Cohen Jon R | SVP, Diagnostic Solutions | Mar 01, 2016 | Option Exercise | $66.73 | 2,323 | 155,003 | 67,409 | Mar 03, 2016, 04:26 PM |
GUINAN MARK | Senior Vice President & CFO | Mar 01, 2016 | Option Exercise | $67.01 | 2,591 | 173,623 | 50,293 | Mar 03, 2016, 04:25 PM |
GUINAN MARK | Senior Vice President & CFO | Mar 01, 2016 | Option Exercise | $67.01 | 966 | 64,732 | 49,327 | Mar 03, 2016, 04:25 PM |
Davis J. E. | SVP, Regional Businesses | Mar 01, 2016 | Option Exercise | $67.01 | 1,870 | 125,309 | 32,448 | Mar 03, 2016, 04:23 PM |
Davis J. E. | SVP, Regional Businesses | Mar 01, 2016 | Option Exercise | $67.01 | 655 | 43,892 | 31,861 | Mar 03, 2016, 04:23 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 01, 2016 | Option Exercise | $67.01 | 1,994 | 133,618 | 47,317 | Mar 03, 2016, 04:21 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 01, 2016 | Option Exercise | $66.72 | 1,604 | 107,025 | 46,632 | Mar 03, 2016, 04:21 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 01, 2016 | Sale | $68.22 | 3,815 | 260,265 | 42,181 | Mar 03, 2016, 04:21 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Mar 01, 2016 | Option Exercise | $67.01 | 2,684 | 179,855 | 84,845 | Mar 03, 2016, 04:20 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Mar 01, 2016 | Option Exercise | $66.72 | 2,227 | 148,579 | 83,923 | Mar 03, 2016, 04:20 PM |
Klug Robert A | VP, Corporate Controller | Mar 01, 2016 | Option Exercise | $67.01 | 184 | 12,330 | 2,830 | Mar 03, 2016, 04:19 PM |
Klug Robert A | VP, Corporate Controller | Mar 01, 2016 | Option Exercise | $67.01 | 72 | 4,825 | 2,797 | Mar 03, 2016, 04:19 PM |
Cunningham Everett | SVP, Commercial | Mar 01, 2016 | Option Exercise | $67.01 | 2,684 | 179,855 | 33,956 | Mar 03, 2016, 04:17 PM |
Cunningham Everett | SVP, Commercial | Mar 01, 2016 | Option Exercise | $66.73 | 2,323 | 155,003 | 32,956 | Mar 03, 2016, 04:17 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Mar 01, 2016 | Option Exercise | $67.01 | 10,273 | 688,394 | 151,051 | Mar 03, 2016, 04:16 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Mar 01, 2016 | Option Exercise | $66.71 | 11,857 | 791,015 | 146,240 | Mar 03, 2016, 04:16 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Feb 25, 2016 | Option Exercise | $66.44 | 1,832 | 121,718 | 140,778 | Feb 29, 2016, 07:41 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 25, 2016 | Option Exercise | $66.44 | 309 | 20,530 | 45,323 | Feb 29, 2016, 07:40 PM |
Klug Robert A | VP, Corporate Controller | Feb 25, 2016 | Option Exercise | $66.44 | 48 | 3,189 | 2,646 | Feb 29, 2016, 07:38 PM |
GUINAN MARK | Senior Vice President & CFO | Feb 25, 2016 | Option Exercise | $66.44 | 550 | 36,542 | 47,702 | Feb 29, 2016, 07:37 PM |
Davis J. E. | SVP, Regional Businesses | Feb 25, 2016 | Option Exercise | $66.44 | 459 | 30,496 | 30,578 | Feb 29, 2016, 07:36 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Feb 25, 2016 | Option Exercise | $66.44 | 422 | 28,038 | 82,161 | Feb 29, 2016, 07:35 PM |
Cunningham Everett | SVP, Commercial | Feb 25, 2016 | Option Exercise | $66.44 | 457 | 30,363 | 31,272 | Feb 29, 2016, 07:34 PM |
Cohen Jon R | SVP, Diagnostic Solutions | Feb 25, 2016 | Option Exercise | $66.44 | 458 | 30,430 | 65,725 | Feb 29, 2016, 07:32 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Feb 16, 2016 | Option Exercise | $61.95 | 2,386 | 147,813 | 120,057 | Feb 18, 2016, 05:00 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 16, 2016 | Option Exercise | $61.95 | 471 | 29,178 | 41,722 | Feb 18, 2016, 04:59 PM |
Klug Robert A | VP, Corporate Controller | Feb 16, 2016 | Option Exercise | $61.95 | 61 | 3,779 | 1,897 | Feb 18, 2016, 04:58 PM |
GUINAN MARK | Senior Vice President & CFO | Feb 16, 2016 | Option Exercise | $61.95 | 739 | 45,781 | 41,937 | Feb 18, 2016, 04:55 PM |
Doherty Catherine T. | SVP, Clin. Franchise Solutions | Feb 16, 2016 | Option Exercise | $61.95 | 609 | 37,728 | 78,072 | Feb 18, 2016, 04:51 PM |
Davis J. E. | SVP, Operations | Feb 16, 2016 | Option Exercise | $61.95 | 595 | 36,860 | 25,022 | Feb 18, 2016, 04:50 PM |
Cunningham Everett | SVP, Commercial | Feb 16, 2016 | Option Exercise | $61.95 | 663 | 41,073 | 27,218 | Feb 18, 2016, 04:49 PM |
Cohen Jon R | SVP and Chief Medical Officer | Feb 16, 2016 | Option Exercise | $61.95 | 657 | 40,701 | 61,672 | Feb 18, 2016, 04:48 PM |
BRITELL JENNE K | Director | Jan 04, 2016 | Option Exercise | $71.38 | 169 | 12,063 | 17,660 | Jan 05, 2016, 05:21 PM |
Gregg Vicky B | Director | Jan 04, 2016 | Option Exercise | $71.38 | 61 | 4,354 | 4,684 | Jan 05, 2016, 05:20 PM |
PFEIFFER GARY M | Director | Jan 04, 2016 | Option Exercise | $71.38 | 494 | 35,262 | 19,685 | Jan 05, 2016, 05:15 PM |
RING TIMOTHY M | Director | Jan 04, 2016 | Option Exercise | $71.38 | 417 | 29,765 | 10,454 | Jan 05, 2016, 05:12 PM |
ZIEGLER JOHN B | Director | Jan 04, 2016 | Option Exercise | $71.38 | 337 | 24,055 | 17,302 | Jan 05, 2016, 05:10 PM |
Cunningham Everett | SVP, Commercial | Dec 14, 2015 | Option Exercise | $67.43 | 1,188 | 80,107 | 27,706 | Dec 16, 2015, 04:49 PM |
Klug Robert A | VP, Corporate Controller | Aug 21, 2015 | Option Exercise | $73.28 | 42 | 3,078 | 1,707 | Aug 24, 2015, 04:24 PM |
GUINAN MARK | Senior Vice President & CFO | Aug 21, 2015 | Option Exercise | $73.28 | 3,462 | 253,695 | 42,676 | Aug 24, 2015, 04:23 PM |
BALDWIN JOHN C MD | Director | Aug 12, 2015 | Sale | $72.00 | 2,266 | 163,152 | 12,949 | Aug 13, 2015, 04:49 PM |
ZIEGLER JOHN B | Director | Aug 06, 2015 | Sale | $74.35 | 2,200 | 163,570 | 16,965 | Aug 10, 2015, 04:21 PM |
Davis J. E. | SVP, Operations | May 21, 2015 | Option Exercise | $73.74 | 1,309 | 96,526 | 24,955 | May 22, 2015, 04:26 PM |
RUSCKOWSKI STEPHEN H | President and CEO | May 04, 2015 | Option Exercise | $71.78 | 5,972 | 428,640 | 120,898 | May 04, 2015, 04:21 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Mar 02, 2015 | Option Exercise | $70.53 | 454 | 32,021 | 126,586 | Mar 03, 2015, 06:30 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Feb 27, 2015 | Option Exercise | $71.25 | 3,523 | 251,014 | 126,031 | Mar 03, 2015, 06:30 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 02, 2015 | Option Exercise | $70.53 | 996 | 70,248 | 45,321 | Mar 03, 2015, 06:29 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 27, 2015 | Option Exercise | $71.25 | 492 | 35,055 | 46,128 | Mar 03, 2015, 06:29 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 03, 2015 | Sale | $71.16 | 3,261 | 232,043 | 42,067 | Mar 03, 2015, 06:29 PM |
Doherty Catherine T. | SVP, Physician Services Bus. | Mar 02, 2015 | Option Exercise | $70.53 | 1,424 | 100,435 | 78,659 | Mar 03, 2015, 06:28 PM |
Doherty Catherine T. | SVP, Physician Services Bus. | Feb 27, 2015 | Option Exercise | $71.25 | 662 | 47,168 | 79,813 | Mar 03, 2015, 06:28 PM |
Cunningham Everett | SVP, Commercial | Feb 27, 2015 | Option Exercise | $71.25 | 662 | 47,168 | 28,280 | Mar 03, 2015, 06:27 PM |
Cohen Jon R | SVP and Chief Medical Officer | Feb 27, 2015 | Option Exercise | $71.25 | 662 | 47,168 | 63,356 | Mar 03, 2015, 06:27 PM |
Cohen Jon R | SVP and Chief Medical Officer | Mar 02, 2015 | Option Exercise | $70.53 | 1,327 | 93,593 | 62,281 | Mar 03, 2015, 06:27 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Mar 02, 2015 | Option Exercise | $70.53 | 370 | 26,096 | 11,837 | Mar 03, 2015, 06:26 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 27, 2015 | Option Exercise | $71.25 | 182 | 12,968 | 12,111 | Mar 03, 2015, 06:26 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Feb 17, 2015 | Option Exercise | $71.41 | 2,391 | 170,741 | 109,882 | Feb 18, 2015, 06:39 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 17, 2015 | Sale | $71.41 | 488 | 34,848 | 42,966 | Feb 18, 2015, 06:39 PM |
GUINAN MARK | Senior Vice President & CFO | Feb 17, 2015 | Option Exercise | $71.42 | 722 | 51,562 | 40,467 | Feb 18, 2015, 06:38 PM |
GUINAN MARK | Senior Vice President & CFO | Feb 17, 2015 | Sale | $71.74 | 280 | 20,087 | 40,236 | Feb 18, 2015, 06:38 PM |
Doherty Catherine T. | SVP, Physician Services Bus. | Feb 17, 2015 | Option Exercise | $71.41 | 638 | 45,560 | 75,556 | Feb 18, 2015, 06:37 PM |
Davis J. E. | SVP, Operations | Feb 17, 2015 | Option Exercise | $71.41 | 598 | 42,703 | 20,703 | Feb 18, 2015, 06:36 PM |
Cunningham Everett | SVP, Commercial | Feb 17, 2015 | Option Exercise | $71.41 | 642 | 45,845 | 23,960 | Feb 18, 2015, 06:35 PM |
Cohen Jon R | SVP and Chief Medical Officer | Feb 17, 2015 | Option Exercise | $71.41 | 633 | 45,203 | 59,099 | Feb 18, 2015, 06:35 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 17, 2015 | Option Exercise | $71.41 | 184 | 13,139 | 12,293 | Feb 18, 2015, 06:34 PM |
STANZIONE DANIEL | Director | Feb 11, 2015 | Option Exercise | $49.94 | 8,000 | 399,520 | 34,337 | Feb 12, 2015, 04:40 PM |
STANZIONE DANIEL | Director | Feb 11, 2015 | Sale | $70.97 | 8,000 | 567,755 | 26,337 | Feb 12, 2015, 04:40 PM |
PFEIFFER GARY M | Director | Feb 04, 2015 | Option Exercise | $49.94 | 8,000 | 399,520 | 24,851 | Feb 05, 2015, 04:50 PM |
PFEIFFER GARY M | Director | Feb 04, 2015 | Sale | $72.43 | 8,000 | 579,466 | 16,851 | Feb 05, 2015, 04:50 PM |
WILENSKY GAIL R | Director | Feb 04, 2015 | Option Exercise | $49.94 | 8,000 | 399,520 | 26,851 | Feb 05, 2015, 04:44 PM |
WILENSKY GAIL R | Director | Feb 04, 2015 | Sale | $72.34 | 8,000 | 578,687 | 18,851 | Feb 05, 2015, 04:44 PM |
ZIEGLER JOHN B | Director | Feb 03, 2015 | Option Exercise | $51.55 | 8,000 | 412,400 | 24,825 | Feb 04, 2015, 06:37 PM |
ZIEGLER JOHN B | Director | Feb 03, 2015 | Sale | $71.88 | 8,000 | 575,040 | 16,825 | Feb 04, 2015, 06:37 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 02, 2015 | Sale | $71.50 | 3,000 | 214,500 | 12,477 | Feb 04, 2015, 06:34 PM |
Cunningham Everett | SVP, Commercial | Dec 15, 2014 | Option Exercise | $64.07 | 1,188 | 76,121 | 24,417 | Dec 17, 2014, 04:39 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Nov 18, 2014 | Option Exercise | $47.49 | 10,000 | 474,900 | 25,187 | Nov 20, 2014, 05:19 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Nov 18, 2014 | Sale | $64.00 | 10,000 | 640,000 | 15,377 | Nov 20, 2014, 05:19 PM |
Cohen Jon R | SVP and Chief Medical Officer | Nov 17, 2014 | Option Exercise | $56.82 | 83,483 | 4,743,778 | 142,614 | Nov 18, 2014, 04:29 PM |
Cohen Jon R | SVP and Chief Medical Officer | Nov 14, 2014 | Option Exercise | $53.78 | 76,546 | 4,116,679 | 157,283 | Nov 18, 2014, 04:29 PM |
Cohen Jon R | SVP and Chief Medical Officer | Nov 17, 2014 | Sale | $63.00 | 98,152 | 6,183,576 | 59,711 | Nov 18, 2014, 04:29 PM |
Cohen Jon R | SVP and Chief Medical Officer | Nov 14, 2014 | Sale | $63.34 | 61,877 | 3,919,258 | 59,131 | Nov 18, 2014, 04:29 PM |
PFEIFFER GARY M | Director | Nov 10, 2014 | Option Exercise | $48.02 | 10,000 | 480,225 | 26,851 | Nov 12, 2014, 04:29 PM |
PFEIFFER GARY M | Director | Nov 10, 2014 | Sale | $61.69 | 10,000 | 616,900 | 16,851 | Nov 12, 2014, 04:29 PM |
Doherty Catherine T. | SVP, Physician Services Bus. | Nov 03, 2014 | Option Exercise | $47.49 | 23,667 | 1,123,946 | 99,850 | Nov 05, 2014, 04:22 PM |
Doherty Catherine T. | SVP, Physician Services Bus. | Nov 03, 2014 | Sale | $62.19 | 23,667 | 1,471,910 | 76,183 | Nov 05, 2014, 04:22 PM |
GUINAN MARK | Senior Vice President & CFO | Aug 20, 2014 | Option Exercise | $61.99 | 3,033 | 188,016 | 41,828 | Aug 20, 2014, 06:10 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Aug 08, 2014 | Option Exercise | $53.19 | 25,000 | 1,329,750 | 101,157 | Aug 11, 2014, 05:07 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Aug 08, 2014 | Sale | $60.12 | 25,000 | 1,502,900 | 76,171 | Aug 11, 2014, 05:07 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Aug 04, 2014 | Option Exercise | $47.49 | 14,377 | 682,764 | 57,700 | Aug 05, 2014, 04:32 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Aug 04, 2014 | Sale | $61.01 | 14,377 | 877,182 | 43,330 | Aug 05, 2014, 04:32 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jul 30, 2014 | Option Exercise | $47.49 | 16,384 | 778,076 | 59,596 | Jul 31, 2014, 04:33 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jul 30, 2014 | Sale | $62.51 | 16,384 | 1,024,103 | 43,323 | Jul 31, 2014, 04:33 PM |
BRITELL JENNE K | Director | Jul 30, 2014 | Option Exercise | $49.94 | 8,000 | 399,520 | 23,151 | Jul 31, 2014, 04:29 PM |
BRITELL JENNE K | Director | Jul 30, 2014 | Sale | $62.37 | 8,000 | 498,960 | 15,151 | Jul 31, 2014, 04:29 PM |
BALDWIN JOHN C MD | Director | Jul 29, 2014 | Option Exercise | $55.76 | 8,000 | 446,080 | 20,875 | Jul 29, 2014, 04:44 PM |
BALDWIN JOHN C MD | Director | Jul 29, 2014 | Sale | $62.31 | 8,000 | 498,480 | 12,875 | Jul 29, 2014, 04:44 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Jul 28, 2014 | Option Exercise | $53.19 | 4,000 | 212,760 | 19,065 | Jul 29, 2014, 04:39 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Jul 28, 2014 | Sale | $61.72 | 4,000 | 246,869 | 15,187 | Jul 29, 2014, 04:39 PM |
ZIEGLER JOHN B | Director | Jul 24, 2014 | Option Exercise | $49.94 | 6,135 | 306,382 | 22,960 | Jul 28, 2014, 04:35 PM |
ZIEGLER JOHN B | Director | Jul 25, 2014 | Option Exercise | $49.94 | 1,865 | 93,138 | 18,690 | Jul 28, 2014, 04:35 PM |
ZIEGLER JOHN B | Director | Jul 24, 2014 | Sale | $61.90 | 6,135 | 379,757 | 16,825 | Jul 28, 2014, 04:35 PM |
ZIEGLER JOHN B | Director | Jul 25, 2014 | Sale | $61.90 | 1,865 | 115,444 | 16,825 | Jul 28, 2014, 04:35 PM |
ZIEGLER JOHN B | Director | May 22, 2014 | Option Exercise | $47.94 | 998 | 47,842 | 19,798 | May 22, 2014, 05:57 PM |
ZIEGLER JOHN B | Director | May 22, 2014 | Sale | $57.65 | 2,973 | 171,402 | 18,800 | May 22, 2014, 05:57 PM |
Davis J. E. | SVP, Operations | May 21, 2014 | Option Exercise | $57.33 | 2,183 | 125,140 | 20,506 | May 22, 2014, 05:05 PM |
Doherty Catherine T. | SVP, Clinical Franchises | May 19, 2014 | Option Exercise | $57.72 | 551 | 31,804 | 76,157 | May 21, 2014, 04:24 PM |
PFEIFFER GARY M | Director | May 07, 2014 | Option Exercise | $49.04 | 10,000 | 490,400 | 23,927 | May 09, 2014, 04:33 PM |
PFEIFFER GARY M | Director | May 07, 2014 | Sale | $55.95 | 10,000 | 559,511 | 13,927 | May 09, 2014, 04:33 PM |
GUINAN MARK | Senior Vice President & CFO | May 05, 2014 | Buy | $55.51 | 4,000 | 222,023 | 44,222 | May 07, 2014, 04:22 PM |
RUSCKOWSKI STEPHEN H | President and CEO | May 02, 2014 | Option Exercise | $56.02 | 8,961 | 501,995 | 110,362 | May 05, 2014, 04:12 PM |
STANZIONE DANIEL | Director | Apr 30, 2014 | Option Exercise | $44.76 | 30,000 | 1,342,900 | 52,151 | May 02, 2014, 04:41 PM |
STANZIONE DANIEL | Director | Apr 30, 2014 | Sale | $55.75 | 30,000 | 1,672,374 | 22,151 | May 02, 2014, 04:41 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Apr 16, 2014 | Option Exercise | $60.03 | 3,814 | 228,935 | 113,079 | Apr 17, 2014, 04:32 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 04, 2014 | Sale | $53.00 | 778 | 41,233 | 43,212 | Mar 05, 2014, 05:04 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 28, 2014 | Option Exercise | $52.92 | 463 | 24,500 | 43,981 | Mar 03, 2014, 04:40 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Feb 28, 2014 | Option Exercise | $52.92 | 661 | 34,977 | 76,685 | Mar 03, 2014, 04:36 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 28, 2014 | Option Exercise | $52.92 | 172 | 9,101 | 15,065 | Mar 03, 2014, 04:35 PM |
Cohen Jon R | SVP and Chief Medical Officer | Feb 28, 2014 | Option Exercise | $52.92 | 617 | 32,649 | 59,131 | Mar 03, 2014, 04:34 PM |
BRITELL JENNE K | Director | Feb 27, 2014 | Option Exercise | $49.04 | 10,000 | 490,400 | 22,227 | Feb 28, 2014, 04:35 PM |
BRITELL JENNE K | Director | Feb 27, 2014 | Sale | $52.74 | 10,000 | 527,393 | 12,227 | Feb 28, 2014, 04:35 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Feb 26, 2014 | Option Exercise | $53.34 | 2,531 | 135,004 | 116,553 | Feb 27, 2014, 05:19 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 26, 2014 | Option Exercise | $53.34 | 491 | 26,190 | 45,271 | Feb 27, 2014, 05:17 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 27, 2014 | Sale | $52.99 | 827 | 43,826 | 44,444 | Feb 27, 2014, 05:17 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Feb 26, 2014 | Option Exercise | $53.34 | 661 | 35,258 | 77,346 | Feb 27, 2014, 05:15 PM |
Cunningham Everett | SVP, Commercial | Feb 26, 2014 | Option Exercise | $53.34 | 665 | 35,471 | 24,776 | Feb 27, 2014, 05:13 PM |
Cohen Jon R | SVP and Chief Medical Officer | Feb 26, 2014 | Option Exercise | $53.34 | 661 | 35,258 | 59,748 | Feb 27, 2014, 05:11 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 26, 2014 | Option Exercise | $53.34 | 177 | 9,441 | 15,237 | Feb 27, 2014, 05:04 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 19, 2014 | Sale | $52.26 | 2,860 | 149,472 | 45,762 | Feb 20, 2014, 04:22 PM |
WILENSKY GAIL R | Director | Feb 18, 2014 | Option Exercise | $44.76 | 30,000 | 1,342,900 | 45,927 | Feb 19, 2014, 04:25 PM |
WILENSKY GAIL R | Director | Feb 18, 2014 | Sale | $52.93 | 30,000 | 1,588,041 | 25,927 | Feb 19, 2014, 04:25 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 18, 2014 | Option Exercise | $52.56 | 1,737 | 91,288 | 48,622 | Feb 18, 2014, 08:12 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Feb 18, 2014 | Option Exercise | $52.56 | 1,441 | 75,732 | 78,007 | Feb 18, 2014, 08:08 PM |
Cohen Jon R | SVP and Chief Medical Officer | Feb 18, 2014 | Option Exercise | $52.56 | 2,290 | 120,351 | 60,409 | Feb 18, 2014, 08:05 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 18, 2014 | Option Exercise | $52.55 | 630 | 33,106 | 15,414 | Feb 18, 2014, 08:03 PM |
BUEHLER WILLIAM F | Director | Feb 12, 2014 | Option Exercise | $44.76 | 30,000 | 1,342,900 | 56,225 | Feb 14, 2014, 04:20 PM |
BUEHLER WILLIAM F | Director | Feb 12, 2014 | Sale | $52.15 | 30,000 | 1,564,449 | 26,225 | Feb 14, 2014, 04:20 PM |
MAIN TIMOTHY L | Director | Feb 06, 2014 | Buy | $50.71 | 5,000 | 253,526 | 5,658 | Feb 07, 2014, 04:58 PM |
Haydon John B. | SVP, Operations | Dec 13, 2013 | Option Exercise | $54.15 | 4,720 | 255,588 | 19,058 | Dec 17, 2013, 04:39 PM |
Cunningham Everett | SVP, Commercial | Dec 13, 2013 | Option Exercise | $54.15 | 2,376 | 128,660 | 18,514 | Dec 17, 2013, 04:37 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Nov 11, 2013 | Option Exercise | $47.49 | 24,239 | 1,151,110 | 69,430 | Nov 13, 2013, 04:33 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Nov 11, 2013 | Sale | $64.02 | 24,239 | 1,551,686 | 45,306 | Nov 13, 2013, 04:33 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Nov 05, 2013 | Option Exercise | $52.24 | 8,000 | 417,960 | 22,167 | Nov 05, 2013, 04:35 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Nov 04, 2013 | Option Exercise | $52.24 | 8,667 | 452,807 | 22,834 | Nov 05, 2013, 04:35 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Nov 04, 2013 | Sale | $62.02 | 8,667 | 537,508 | 14,167 | Nov 05, 2013, 04:35 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Nov 05, 2013 | Sale | $63.00 | 8,000 | 504,000 | 14,197 | Nov 05, 2013, 04:35 PM |
BALDWIN JOHN C MD | Director | Nov 05, 2013 | Sale | $63.00 | 658 | 41,454 | 9,951 | Nov 05, 2013, 04:33 PM |
BALDWIN JOHN C MD | Director | Oct 31, 2013 | Option Exercise | $51.55 | 8,000 | 412,400 | 18,609 | Nov 04, 2013, 04:39 PM |
BALDWIN JOHN C MD | Director | Oct 31, 2013 | Sale | $59.70 | 8,000 | 477,600 | 10,609 | Nov 04, 2013, 04:39 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Oct 29, 2013 | Option Exercise | $40.43 | 6,000 | 242,565 | 20,086 | Oct 30, 2013, 04:27 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Oct 29, 2013 | Sale | $59.00 | 6,000 | 354,000 | 14,167 | Oct 30, 2013, 04:27 PM |
PFEIFFER GARY M | Director | Oct 25, 2013 | Sale | $58.10 | 2,000 | 116,200 | 13,927 | Oct 25, 2013, 04:31 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Sep 17, 2013 | Option Exercise | $52.24 | 27,621 | 1,443,059 | 99,911 | Sep 18, 2013, 04:43 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Sep 16, 2013 | Option Exercise | $52.24 | 15,713 | 820,926 | 88,003 | Sep 18, 2013, 04:43 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Sep 17, 2013 | Sale | $62.00 | 27,621 | 1,712,502 | 72,295 | Sep 18, 2013, 04:43 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Sep 16, 2013 | Sale | $62.00 | 15,713 | 974,206 | 72,290 | Sep 18, 2013, 04:43 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Aug 14, 2013 | Option Exercise | $40.43 | 33,000 | 1,334,108 | 105,079 | Aug 15, 2013, 04:32 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Aug 14, 2013 | Sale | $59.85 | 33,000 | 1,975,126 | 72,290 | Aug 15, 2013, 04:32 PM |
ZIEGLER JOHN B | Director | Aug 12, 2013 | Sale | $59.45 | 1,953 | 116,109 | 15,876 | Aug 12, 2013, 04:46 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Aug 08, 2013 | Option Exercise | $40.43 | 12,000 | 485,130 | 24,770 | Aug 12, 2013, 04:45 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Aug 08, 2013 | Sale | $59.33 | 10,864 | 644,585 | 14,086 | Aug 12, 2013, 04:45 PM |
BRITELL JENNE K | Director | Jul 23, 2013 | Sale | $58.99 | 4,200 | 247,767 | 12,227 | Jul 25, 2013, 04:40 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jun 17, 2013 | Option Exercise | $45.96 | 116,746 | 5,365,776 | 161,874 | Jun 19, 2013, 04:35 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jun 18, 2013 | Option Exercise | $40.43 | 9,921 | 401,081 | 171,795 | Jun 19, 2013, 04:35 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jun 18, 2013 | Sale | $62.46 | 9,921 | 619,684 | 45,191 | Jun 19, 2013, 04:35 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jun 17, 2013 | Sale | $62.65 | 116,746 | 7,314,487 | 55,049 | Jun 19, 2013, 04:35 PM |
ZIEGLER JOHN B | Director | May 22, 2013 | Option Exercise | $44.70 | 31,362 | 1,401,767 | 49,191 | May 23, 2013, 06:47 PM |
ZIEGLER JOHN B | Director | May 22, 2013 | Sale | $62.00 | 31,362 | 1,944,444 | 17,829 | May 23, 2013, 06:47 PM |
Doherty Catherine T. | SVP, Clinical Franchises | May 16, 2013 | Option Exercise | $59.90 | 276 | 16,534 | 72,079 | May 17, 2013, 04:32 PM |
BALDWIN JOHN C MD | Director | May 14, 2013 | Sale | $59.41 | 1,214 | 72,122 | 8,634 | May 15, 2013, 04:39 PM |
WILENSKY GAIL R | Director | May 02, 2013 | Option Exercise | $55.40 | 10,000 | 554,000 | 23,952 | May 03, 2013, 04:33 PM |
WILENSKY GAIL R | Director | May 02, 2013 | Sale | $57.20 | 10,000 | 572,008 | 13,952 | May 03, 2013, 04:33 PM |
RUSCKOWSKI STEPHEN H | President and CEO | May 01, 2013 | Option Exercise | $56.69 | 2,721 | 154,253 | 91,580 | May 03, 2013, 04:32 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Apr 15, 2013 | Option Exercise | $58.96 | 4,725 | 278,586 | 94,116 | Apr 17, 2013, 04:39 PM |
ZIEGLER JOHN B | Director | Apr 11, 2013 | Option Exercise | $38.50 | 1,470 | 56,592 | 17,324 | Apr 12, 2013, 04:39 PM |
ZIEGLER JOHN B | Director | Apr 11, 2013 | Sale | $58.35 | 1,470 | 85,774 | 15,854 | Apr 12, 2013, 04:39 PM |
ORDONEZ KATHY | SVP, Diagnostic Solutions | Mar 31, 2013 | Option Exercise | $56.22 | 245 | 13,775 | 9,569 | Apr 02, 2013, 04:38 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Mar 05, 2013 | Option Exercise | $56.35 | 1,588 | 89,476 | 98,591 | Mar 07, 2013, 04:33 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 05, 2013 | Option Exercise | $56.35 | 1,183 | 66,656 | 47,120 | Mar 07, 2013, 04:32 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 06, 2013 | Sale | $56.46 | 1,992 | 112,465 | 47,100 | Mar 07, 2013, 04:32 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Mar 05, 2013 | Option Exercise | $56.35 | 3,084 | 173,768 | 126,722 | Mar 07, 2013, 04:30 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Mar 05, 2013 | Option Exercise | $56.35 | 934 | 52,626 | 72,146 | Mar 07, 2013, 04:29 PM |
Cohen Jon R | SVP and Chief Medical Officer | Mar 05, 2013 | Option Exercise | $56.35 | 2,001 | 112,746 | 54,232 | Mar 07, 2013, 04:28 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Mar 05, 2013 | Option Exercise | $56.35 | 395 | 22,256 | 12,770 | Mar 07, 2013, 04:26 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 04, 2013 | Option Exercise | $55.97 | 463 | 25,914 | 45,898 | Mar 06, 2013, 04:45 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 06, 2013 | Sale | $56.64 | 778 | 44,063 | 45,128 | Mar 06, 2013, 04:45 PM |
ORDONEZ KATHY | SVP, Diagnostic Solutions | Mar 04, 2013 | Option Exercise | $55.97 | 364 | 20,373 | 9,814 | Mar 06, 2013, 04:43 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Mar 04, 2013 | Option Exercise | $55.97 | 1,182 | 66,157 | 123,281 | Mar 06, 2013, 04:40 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Mar 04, 2013 | Option Exercise | $55.97 | 661 | 36,996 | 70,575 | Mar 06, 2013, 04:39 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Mar 04, 2013 | Option Exercise | $55.97 | 171 | 9,571 | 12,106 | Mar 06, 2013, 04:38 PM |
Cohen Jon R | SVP and Chief Medical Officer | Mar 04, 2013 | Option Exercise | $55.97 | 617 | 34,533 | 52,000 | Mar 06, 2013, 04:36 PM |
ZIEGLER JOHN B | Director | Feb 20, 2013 | Sale | $57.42 | 2,000 | 114,840 | 15,854 | Feb 22, 2013, 04:33 PM |
BRITELL JENNE K | Director | Feb 20, 2013 | Option Exercise | $55.40 | 10,000 | 554,000 | 24,452 | Feb 22, 2013, 04:31 PM |
BRITELL JENNE K | Director | Feb 20, 2013 | Sale | $57.30 | 10,000 | 572,957 | 14,452 | Feb 22, 2013, 04:31 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 15, 2013 | Option Exercise | $56.97 | 857 | 48,823 | 42,529 | Feb 19, 2013, 04:50 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 19, 2013 | Sale | $57.53 | 1,442 | 82,961 | 41,087 | Feb 19, 2013, 04:50 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 15, 2013 | Option Exercise | $56.97 | 1,761 | 100,324 | 115,133 | Feb 19, 2013, 04:48 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 15, 2013 | Option Exercise | $56.97 | 279 | 15,895 | 10,298 | Feb 19, 2013, 04:44 PM |
Cohen Jon R | SVP and Chief Medical Officer | Feb 15, 2013 | Option Exercise | $56.97 | 1,142 | 65,060 | 45,434 | Feb 19, 2013, 04:43 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Feb 15, 2013 | Option Exercise | $56.97 | 712 | 40,563 | 64,133 | Feb 19, 2013, 04:41 PM |
Cohen Jon R | SVP and Chief Medical Officer | Feb 10, 2013 | Option Exercise | $58.45 | 2,426 | 141,800 | 46,576 | Feb 12, 2013, 05:04 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 10, 2013 | Option Exercise | $58.45 | 1,358 | 79,375 | 46,867 | Feb 12, 2013, 05:00 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 12, 2013 | Sale | $57.48 | 3,481 | 200,074 | 43,386 | Feb 12, 2013, 05:00 PM |
Doherty Catherine T. | SVP, Clinical Franchises | Feb 10, 2013 | Option Exercise | $58.45 | 1,453 | 84,928 | 64,845 | Feb 12, 2013, 04:55 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 10, 2013 | Option Exercise | $58.45 | 3,726 | 217,785 | 116,894 | Feb 12, 2013, 04:37 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 10, 2013 | Option Exercise | $58.45 | 662 | 38,694 | 10,577 | Feb 12, 2013, 04:34 PM |
PFEIFFER GARY M | Director | Jan 17, 2013 | Option Exercise | $55.40 | 10,000 | 554,000 | 23,952 | Jan 18, 2013, 04:30 PM |
PFEIFFER GARY M | Director | Jan 17, 2013 | Sale | $60.00 | 10,000 | 600,000 | 13,952 | Jan 18, 2013, 04:30 PM |
ORDONEZ KATHY | SVP, Discovery & Development | Dec 31, 2012 | Option Exercise | $58.24 | 239 | 13,921 | 10,166 | Jan 02, 2013, 04:26 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Oct 03, 2012 | Option Exercise | $40.43 | 46,667 | 1,886,630 | 201,233 | Oct 05, 2012, 04:24 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Oct 03, 2012 | Sale | $64.00 | 46,667 | 2,986,688 | 154,603 | Oct 05, 2012, 04:24 PM |
ORDONEZ KATHY | SVP, Discovery & Development | Sep 30, 2012 | Option Exercise | $63.19 | 239 | 15,101 | 10,400 | Oct 02, 2012, 04:34 PM |
ZIEGLER JOHN B | Director | Sep 06, 2012 | Option Exercise | $55.40 | 10,000 | 554,000 | 27,854 | Sep 07, 2012, 04:30 PM |
ZIEGLER JOHN B | Director | Sep 06, 2012 | Sale | $62.32 | 10,000 | 623,192 | 17,854 | Sep 07, 2012, 04:30 PM |
WILENSKY GAIL R | Director | Aug 15, 2012 | Option Exercise | $30.45 | 20,000 | 609,100 | 33,952 | Aug 16, 2012, 04:18 PM |
WILENSKY GAIL R | Director | Aug 15, 2012 | Sale | $59.24 | 20,000 | 1,184,718 | 13,952 | Aug 16, 2012, 04:18 PM |
BUEHLER WILLIAM F | Director | Aug 10, 2012 | Option Exercise | $38.77 | 30,000 | 1,163,100 | 44,250 | Aug 14, 2012, 04:12 PM |
BUEHLER WILLIAM F | Director | Aug 10, 2012 | Sale | $59.31 | 30,000 | 1,779,164 | 24,250 | Aug 14, 2012, 04:12 PM |
Doherty Catherine T. | SVP, Physician Services | Aug 08, 2012 | Option Exercise | $52.24 | 40,000 | 2,089,400 | 105,914 | Aug 09, 2012, 04:20 PM |
Doherty Catherine T. | SVP, Physician Services | Aug 08, 2012 | Sale | $60.11 | 40,000 | 2,404,324 | 66,016 | Aug 09, 2012, 04:20 PM |
BALDWIN JOHN C MD | Director | Aug 08, 2012 | Option Exercise | $55.40 | 10,000 | 554,000 | 21,618 | Aug 09, 2012, 04:18 PM |
BALDWIN JOHN C MD | Director | Aug 08, 2012 | Sale | $60.00 | 11,770 | 706,165 | 11,618 | Aug 09, 2012, 04:18 PM |
RUSCKOWSKI STEPHEN H | President and CEO | Aug 07, 2012 | Buy | $59.34 | 5,000 | 296,677 | 68,034 | Aug 07, 2012, 04:20 PM |
ZIEGLER JOHN B | Director | Aug 03, 2012 | Sale | $59.26 | 2,800 | 165,916 | 17,854 | Aug 06, 2012, 04:09 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Aug 01, 2012 | Option Exercise | $42.13 | 86,445 | 3,642,354 | 134,474 | Aug 02, 2012, 04:07 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jul 31, 2012 | Option Exercise | $24.76 | 40,222 | 995,897 | 65,435 | Aug 02, 2012, 04:07 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Aug 01, 2012 | Sale | $58.68 | 86,445 | 5,072,299 | 48,111 | Aug 02, 2012, 04:07 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Jul 31, 2012 | Sale | $58.59 | 28,814 | 1,688,270 | 36,621 | Aug 02, 2012, 04:07 PM |
STANZIONE DANIEL | Director | Jul 12, 2012 | Option Exercise | $38.77 | 30,000 | 1,163,100 | 50,176 | Jul 13, 2012, 04:13 PM |
STANZIONE DANIEL | Director | Jul 12, 2012 | Sale | $62.00 | 30,000 | 1,860,000 | 20,176 | Jul 13, 2012, 04:13 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Jun 29, 2012 | Option Exercise | $52.24 | 15,000 | 783,525 | 25,941 | Jul 03, 2012, 01:31 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Jun 29, 2012 | Sale | $59.54 | 15,000 | 893,100 | 10,973 | Jul 03, 2012, 01:31 PM |
ORDONEZ KATHY | SVP, Discovery & Development | Jun 30, 2012 | Option Exercise | $59.77 | 239 | 14,285 | 10,635 | Jul 03, 2012, 01:30 PM |
ZIEGLER JOHN B | Director | Jun 29, 2012 | Option Exercise | $31.13 | 1,460 | 45,444 | 22,114 | Jul 03, 2012, 01:28 PM |
ZIEGLER JOHN B | Director | Jun 29, 2012 | Sale | $60.00 | 1,460 | 87,600 | 20,654 | Jul 03, 2012, 01:28 PM |
ZIEGLER JOHN B | Director | Jun 28, 2012 | Option Exercise | $30.45 | 20,000 | 609,100 | 40,654 | Jul 02, 2012, 05:22 PM |
ZIEGLER JOHN B | Director | Jun 28, 2012 | Sale | $59.00 | 20,000 | 1,180,000 | 20,654 | Jul 02, 2012, 05:22 PM |
ZIEGLER JOHN B | Director | May 30, 2012 | Option Exercise | $29.46 | 864 | 25,452 | 21,518 | May 31, 2012, 04:40 PM |
ZIEGLER JOHN B | Director | May 30, 2012 | Sale | $58.13 | 864 | 50,224 | 20,654 | May 31, 2012, 04:40 PM |
Doherty Catherine T. | SVP, Physician Services | May 16, 2012 | Option Exercise | $57.18 | 343 | 19,613 | 65,914 | May 18, 2012, 03:00 PM |
Cohen Jon R | SVP, Hosp. Services and CMO | May 13, 2012 | Option Exercise | $57.65 | 2,991 | 172,446 | 47,972 | May 15, 2012, 04:18 PM |
RUSCKOWSKI STEPHEN H | President and CEO | May 08, 2012 | Buy | $56.89 | 20,000 | 1,137,748 | 63,034 | May 09, 2012, 04:40 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | May 08, 2012 | Sale | $56.83 | 1 | 57 | 0 | May 09, 2012, 04:39 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | May 01, 2012 | Sale | $58.43 | 2,305 | 134,686 | 1 | May 03, 2012, 05:53 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | May 01, 2012 | Option Exercise | $57.50 | 7,610 | 437,575 | 10,941 | May 03, 2012, 04:35 PM |
PFEIFFER GARY M | Director | May 02, 2012 | Option Exercise | $53.27 | 10,000 | 532,675 | 21,977 | May 03, 2012, 04:34 PM |
PFEIFFER GARY M | Director | May 02, 2012 | Sale | $58.30 | 10,000 | 583,041 | 11,977 | May 03, 2012, 04:34 PM |
BALDWIN JOHN C MD | Director | May 01, 2012 | Option Exercise | $49.94 | 8,000 | 399,520 | 19,977 | May 03, 2012, 04:33 PM |
BALDWIN JOHN C MD | Director | May 01, 2012 | Sale | $57.50 | 10,334 | 594,205 | 9,643 | May 03, 2012, 04:33 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Apr 30, 2012 | Option Exercise | $57.51 | 26,893 | 1,546,616 | 243,713 | May 02, 2012, 04:24 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Apr 02, 2012 | Option Exercise | $40.43 | 46,666 | 1,886,590 | 201,232 | Apr 03, 2012, 04:20 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Apr 02, 2012 | Sale | $62.00 | 46,666 | 2,893,292 | 154,566 | Apr 03, 2012, 04:20 PM |
ORDONEZ KATHY | SVP, Discovery & Development | Apr 02, 2012 | Option Exercise | $61.04 | 239 | 14,589 | 10,870 | Apr 03, 2012, 04:19 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 29, 2012 | Option Exercise | $58.24 | 4,117 | 239,774 | 43,828 | Mar 02, 2012, 04:50 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 01, 2012 | Sale | $57.40 | 7,207 | 413,656 | 36,621 | Mar 02, 2012, 04:50 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 29, 2012 | Option Exercise | $58.24 | 25,950 | 1,511,328 | 270,289 | Mar 02, 2012, 04:49 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Feb 29, 2012 | Option Exercise | $58.24 | 5,077 | 295,684 | 89,232 | Mar 02, 2012, 04:48 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 29, 2012 | Option Exercise | $58.24 | 10,788 | 628,293 | 154,566 | Mar 02, 2012, 04:47 PM |
Doherty Catherine T. | SVP, Physician Services | Feb 29, 2012 | Option Exercise | $58.24 | 3,248 | 189,164 | 66,156 | Mar 02, 2012, 04:45 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 29, 2012 | Option Exercise | $58.24 | 1,373 | 79,964 | 18,411 | Mar 02, 2012, 04:44 PM |
Cohen Jon R | SVP, Hosp. Services and CMO | Feb 29, 2012 | Option Exercise | $58.24 | 5,489 | 319,679 | 50,625 | Mar 02, 2012, 04:41 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Feb 24, 2012 | Option Exercise | $56.60 | 15,561 | 880,789 | 88,934 | Feb 27, 2012, 04:14 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Feb 24, 2012 | Sale | $57.45 | 15,561 | 893,979 | 73,373 | Feb 27, 2012, 04:14 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 21, 2012 | Option Exercise | $56.87 | 7,078 | 402,557 | 21,248 | Feb 22, 2012, 04:15 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 21, 2012 | Sale | $57.50 | 7,078 | 406,985 | 14,170 | Feb 22, 2012, 04:15 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 16, 2012 | Option Exercise | $57.08 | 5,268 | 300,671 | 240,254 | Feb 17, 2012, 04:42 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 16, 2012 | Sale | $57.38 | 1,462 | 83,888 | 31,656 | Feb 17, 2012, 04:40 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Feb 15, 2012 | Option Exercise | $56.80 | 1,124 | 63,843 | 73,373 | Feb 16, 2012, 04:23 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 15, 2012 | Option Exercise | $56.80 | 2,190 | 124,392 | 132,079 | Feb 16, 2012, 04:22 PM |
Doherty Catherine T. | SVP, Physician Services Bus. | Feb 15, 2012 | Option Exercise | $56.80 | 694 | 39,419 | 53,374 | Feb 16, 2012, 04:21 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 15, 2012 | Option Exercise | $56.80 | 279 | 15,847 | 14,170 | Feb 16, 2012, 04:20 PM |
Cohen Jon R | SVP, Hosp. Svcs. Bus. and CMO | Feb 15, 2012 | Option Exercise | $56.80 | 1,114 | 63,275 | 34,396 | Feb 16, 2012, 04:19 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 15, 2012 | Option Exercise | $56.80 | 836 | 47,485 | 33,118 | Feb 16, 2012, 04:18 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 14, 2012 | Sale | $57.40 | 4,544 | 260,822 | 36,996 | Feb 16, 2012, 04:18 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 13, 2012 | Option Exercise | $57.12 | 1,797 | 102,636 | 38,498 | Feb 14, 2012, 12:25 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 10, 2012 | Option Exercise | $57.12 | 918 | 52,432 | 40,140 | Feb 14, 2012, 12:25 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 10, 2012 | Option Exercise | $57.12 | 5,545 | 316,703 | 194,581 | Feb 14, 2012, 12:24 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 13, 2012 | Option Exercise | $57.12 | 11,090 | 633,405 | 183,491 | Feb 14, 2012, 12:24 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Feb 13, 2012 | Option Exercise | $57.12 | 2,177 | 124,339 | 74,497 | Feb 14, 2012, 12:23 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Feb 10, 2012 | Option Exercise | $57.12 | 1,191 | 68,024 | 76,674 | Feb 14, 2012, 12:23 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 13, 2012 | Option Exercise | $57.12 | 3,616 | 206,528 | 134,269 | Feb 14, 2012, 12:21 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 10, 2012 | Option Exercise | $57.12 | 1,808 | 103,264 | 137,867 | Feb 14, 2012, 12:21 PM |
Doherty Catherine T. | SVP, Physician Services Bus. | Feb 13, 2012 | Option Exercise | $57.12 | 1,428 | 81,560 | 54,068 | Feb 14, 2012, 12:20 PM |
Doherty Catherine T. | SVP, Physician Services Bus. | Feb 10, 2012 | Option Exercise | $57.12 | 734 | 41,922 | 55,323 | Feb 14, 2012, 12:20 PM |
Cohen Jon R | SVP, Hosp. Svcs. Bus. and CMO | Feb 10, 2012 | Option Exercise | $57.12 | 1,202 | 68,652 | 35,510 | Feb 14, 2012, 12:20 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 13, 2012 | Option Exercise | $57.12 | 638 | 36,439 | 14,449 | Feb 14, 2012, 12:19 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 10, 2012 | Option Exercise | $57.12 | 328 | 18,734 | 14,931 | Feb 14, 2012, 12:19 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Feb 03, 2012 | Option Exercise | $55.65 | 13,333 | 741,981 | 91,072 | Feb 07, 2012, 04:05 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Feb 03, 2012 | Sale | $58.50 | 13,333 | 779,981 | 77,865 | Feb 07, 2012, 04:05 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 01, 2012 | Option Exercise | $48.74 | 20,556 | 1,001,899 | 220,682 | Feb 01, 2012, 04:16 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jan 30, 2012 | Sale | $58.17 | 90,000 | 5,235,516 | 200,126 | Feb 01, 2012, 04:16 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 01, 2012 | Sale | $58.38 | 20,556 | 1,200,026 | 200,126 | Feb 01, 2012, 04:16 PM |
WILENSKY GAIL R | Director | Jan 27, 2012 | Option Exercise | $49.40 | 30,000 | 1,481,975 | 31,977 | Jan 30, 2012, 04:44 PM |
WILENSKY GAIL R | Director | Jan 27, 2012 | Sale | $58.93 | 30,000 | 1,767,868 | 11,977 | Jan 30, 2012, 04:44 PM |
STANZIONE DANIEL | Director | Jan 27, 2012 | Option Exercise | $49.40 | 30,000 | 1,481,975 | 38,201 | Jan 30, 2012, 04:42 PM |
STANZIONE DANIEL | Director | Jan 27, 2012 | Sale | $59.00 | 30,000 | 1,770,006 | 18,201 | Jan 30, 2012, 04:42 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jan 26, 2012 | Option Exercise | $52.24 | 113,334 | 5,920,002 | 253,009 | Jan 30, 2012, 04:41 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jan 26, 2012 | Sale | $59.15 | 113,334 | 6,704,271 | 152,405 | Jan 30, 2012, 04:41 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jan 27, 2012 | Option Exercise | $40.43 | 119,732 | 4,840,466 | 409,559 | Jan 30, 2012, 04:40 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jan 26, 2012 | Option Exercise | $40.43 | 220,268 | 8,904,885 | 510,095 | Jan 30, 2012, 04:40 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jan 27, 2012 | Sale | $59.04 | 119,732 | 7,069,013 | 290,126 | Jan 30, 2012, 04:40 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jan 26, 2012 | Sale | $59.12 | 220,268 | 13,022,420 | 289,827 | Jan 30, 2012, 04:40 PM |
BALDWIN JOHN C MD | Director | Jan 26, 2012 | Option Exercise | $53.27 | 10,000 | 532,675 | 21,977 | Jan 30, 2012, 04:39 PM |
BALDWIN JOHN C MD | Director | Jan 26, 2012 | Sale | $59.00 | 10,000 | 590,005 | 11,977 | Jan 30, 2012, 04:39 PM |
BUEHLER WILLIAM F | Director | Jan 26, 2012 | Option Exercise | $49.40 | 30,000 | 1,481,975 | 52,275 | Jan 30, 2012, 04:37 PM |
BUEHLER WILLIAM F | Director | Jan 26, 2012 | Sale | $58.83 | 30,000 | 1,764,774 | 22,275 | Jan 30, 2012, 04:37 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jan 03, 2012 | Option Exercise | $48.74 | 20,556 | 1,001,899 | 310,383 | Jan 04, 2012, 04:07 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jan 03, 2012 | Sale | $58.66 | 20,556 | 1,205,862 | 289,827 | Jan 04, 2012, 04:07 PM |
ORDONEZ KATHY | SVP, Discovery & Development | Dec 31, 2011 | Option Exercise | $58.16 | 266 | 15,471 | 7,235 | Jan 03, 2012, 04:07 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Dec 21, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,175 | Dec 22, 2011, 04:18 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Dec 21, 2011 | Sale | $57.75 | 4,150 | 239,671 | 139,675 | Dec 22, 2011, 04:18 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Dec 01, 2011 | Option Exercise | $48.74 | 20,556 | 1,001,899 | 310,383 | Dec 02, 2011, 04:23 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Dec 01, 2011 | Sale | $57.95 | 20,556 | 1,191,187 | 289,827 | Dec 02, 2011, 04:23 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Dec 01, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,175 | Dec 02, 2011, 04:22 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Dec 01, 2011 | Sale | $58.15 | 4,150 | 241,317 | 139,675 | Dec 02, 2011, 04:22 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Nov 21, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,175 | Nov 22, 2011, 04:14 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Nov 21, 2011 | Sale | $54.40 | 4,150 | 225,760 | 139,675 | Nov 22, 2011, 04:14 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Nov 08, 2011 | Option Exercise | $48.74 | 13,334 | 649,899 | 28,468 | Nov 10, 2011, 04:18 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Nov 08, 2011 | Sale | $57.50 | 13,334 | 766,705 | 15,259 | Nov 10, 2011, 04:18 PM |
BRITELL JENNE K | Director | Nov 03, 2011 | Option Exercise | $47.45 | 7,500 | 355,875 | 19,977 | Nov 03, 2011, 04:20 PM |
BRITELL JENNE K | Director | Nov 03, 2011 | Sale | $55.70 | 7,500 | 417,750 | 12,477 | Nov 03, 2011, 04:20 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Nov 01, 2011 | Option Exercise | $48.74 | 20,556 | 1,001,899 | 310,383 | Nov 03, 2011, 04:19 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Nov 01, 2011 | Sale | $54.69 | 20,556 | 1,124,142 | 289,827 | Nov 03, 2011, 04:19 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Nov 01, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,163 | Nov 03, 2011, 04:17 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Nov 01, 2011 | Sale | $54.80 | 4,150 | 227,423 | 139,675 | Nov 03, 2011, 04:17 PM |
ZIEGLER JOHN B | Director | Oct 28, 2011 | Option Exercise | $52.98 | 12,997 | 688,607 | 31,676 | Nov 01, 2011, 04:26 PM |
ZIEGLER JOHN B | Director | Oct 28, 2011 | Sale | $57.28 | 12,997 | 744,501 | 18,679 | Nov 01, 2011, 04:26 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Oct 28, 2011 | Option Exercise | $52.24 | 19,259 | 1,005,994 | 96,842 | Nov 01, 2011, 04:25 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Oct 28, 2011 | Sale | $57.50 | 19,259 | 1,107,393 | 77,739 | Nov 01, 2011, 04:25 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Oct 28, 2011 | Option Exercise | $24.76 | 50,000 | 1,238,000 | 339,827 | Nov 01, 2011, 04:24 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Oct 28, 2011 | Sale | $57.41 | 50,000 | 2,870,500 | 289,827 | Nov 01, 2011, 04:24 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Oct 27, 2011 | Option Exercise | $41.00 | 116,000 | 4,755,730 | 109,058 | Oct 31, 2011, 03:39 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Oct 27, 2011 | Sale | $56.68 | 116,000 | 6,574,892 | 41,058 | Oct 31, 2011, 03:39 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Oct 25, 2011 | Option Exercise | $48.74 | 48,047 | 2,341,811 | 337,688 | Oct 27, 2011, 04:09 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Oct 25, 2011 | Sale | $56.49 | 48,047 | 2,714,175 | 289,827 | Oct 27, 2011, 04:09 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Oct 21, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 143,813 | Oct 25, 2011, 04:13 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Oct 21, 2011 | Sale | $49.29 | 4,150 | 204,554 | 139,663 | Oct 25, 2011, 04:13 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Oct 03, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,163 | Oct 05, 2011, 04:23 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Oct 03, 2011 | Sale | $49.23 | 4,150 | 204,315 | 139,663 | Oct 05, 2011, 04:23 PM |
ORDONEZ KATHY | SVP, Discovery & Development | Sep 30, 2011 | Option Exercise | $50.10 | 304 | 15,230 | 7,500 | Oct 04, 2011, 04:20 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Sep 21, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,163 | Sep 23, 2011, 04:14 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Sep 21, 2011 | Sale | $49.51 | 4,150 | 205,467 | 139,663 | Sep 23, 2011, 04:14 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Sep 01, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,163 | Sep 06, 2011, 04:29 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Sep 01, 2011 | Sale | $49.98 | 4,150 | 207,410 | 139,663 | Sep 06, 2011, 04:29 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Aug 29, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 143,813 | Aug 31, 2011, 04:18 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Aug 29, 2011 | Sale | $49.00 | 4,150 | 203,350 | 139,663 | Aug 31, 2011, 04:18 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Aug 17, 2011 | Sale | $49.29 | 1,500 | 73,939 | 15,134 | Aug 18, 2011, 04:37 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Aug 01, 2011 | Option Exercise | $48.74 | 13,620 | 663,839 | 370,692 | Aug 03, 2011, 04:09 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Aug 01, 2011 | Sale | $54.12 | 13,620 | 737,093 | 357,262 | Aug 03, 2011, 04:09 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Aug 01, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,152 | Aug 03, 2011, 04:07 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Aug 01, 2011 | Sale | $54.27 | 4,150 | 225,218 | 139,663 | Aug 03, 2011, 04:07 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jul 21, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,152 | Jul 25, 2011, 11:52 AM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jul 21, 2011 | Sale | $57.18 | 4,150 | 237,304 | 139,652 | Jul 25, 2011, 11:52 AM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jul 01, 2011 | Option Exercise | $48.74 | 20,555 | 1,001,851 | 377,627 | Jul 05, 2011, 04:45 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jul 01, 2011 | Sale | $58.96 | 20,555 | 1,211,954 | 357,072 | Jul 05, 2011, 04:45 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jul 01, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,152 | Jul 05, 2011, 04:41 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jul 01, 2011 | Sale | $58.98 | 4,150 | 244,749 | 139,652 | Jul 05, 2011, 04:41 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jun 21, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,152 | Jun 22, 2011, 11:45 AM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jun 21, 2011 | Sale | $60.68 | 4,150 | 251,811 | 139,652 | Jun 22, 2011, 11:45 AM |
Simmons Wayne R. | Vice President, Operations | Jun 16, 2011 | Option Exercise | $48.74 | 16,000 | 779,840 | 63,109 | Jun 20, 2011, 04:31 PM |
Simmons Wayne R. | Vice President, Operations | Jun 16, 2011 | Sale | $60.00 | 16,000 | 960,000 | 47,150 | Jun 20, 2011, 04:31 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Jun 16, 2011 | Sale | $60.20 | 3,815 | 229,663 | 77,583 | Jun 20, 2011, 04:28 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Jun 14, 2011 | Sale | $59.70 | 4,668 | 278,680 | 81,398 | Jun 16, 2011, 04:38 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | Jun 13, 2011 | Sale | $59.20 | 10,615 | 628,408 | 86,066 | Jun 14, 2011, 04:29 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jun 01, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 143,802 | Jun 03, 2011, 04:06 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Jun 01, 2011 | Sale | $58.10 | 4,150 | 241,103 | 141,302 | Jun 03, 2011, 04:06 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jun 01, 2011 | Option Exercise | $48.74 | 20,555 | 1,001,851 | 377,627 | Jun 02, 2011, 04:23 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Jun 01, 2011 | Sale | $58.06 | 20,555 | 1,193,512 | 357,072 | Jun 02, 2011, 04:23 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | May 23, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,152 | May 25, 2011, 04:18 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | May 23, 2011 | Sale | $57.46 | 4,150 | 238,456 | 139,652 | May 25, 2011, 04:18 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | May 18, 2011 | Option Exercise | $47.49 | 21,112 | 1,002,609 | 117,773 | May 19, 2011, 04:33 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | May 17, 2011 | Sale | $57.93 | 1,809 | 104,795 | 1,039 | May 19, 2011, 04:33 PM |
Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | May 18, 2011 | Sale | $58.10 | 21,112 | 1,226,506 | 106,661 | May 19, 2011, 04:33 PM |
Cohen Jon R | SVP and Chief Medical Officer | May 13, 2011 | Option Exercise | $57.60 | 1,173 | 67,565 | 35,852 | May 16, 2011, 04:25 PM |
Miller Joan Elizabeth | SVP-Pathology & Hosp. Services | May 12, 2011 | Option Exercise | $47.49 | 40,555 | 1,925,957 | 137,137 | May 16, 2011, 04:23 PM |
Miller Joan Elizabeth | SVP-Pathology & Hosp. Services | May 12, 2011 | Sale | $57.74 | 1,810 | 104,509 | 2,850 | May 16, 2011, 04:23 PM |
Miller Joan Elizabeth | SVP-Pathology & Hosp. Services | May 12, 2011 | Sale | $57.40 | 40,555 | 2,327,774 | 116,582 | May 16, 2011, 04:23 PM |
Simmons Wayne R. | Vice President, Operations | May 11, 2011 | Sale | $57.00 | 10,000 | 570,000 | 47,109 | May 13, 2011, 04:06 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | May 02, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,141 | May 04, 2011, 04:17 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | May 02, 2011 | Sale | $56.46 | 4,150 | 234,314 | 139,652 | May 04, 2011, 04:17 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | May 02, 2011 | Option Exercise | $48.74 | 20,555 | 1,001,851 | 377,437 | May 04, 2011, 04:09 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | May 02, 2011 | Sale | $56.68 | 20,555 | 1,165,144 | 357,072 | May 04, 2011, 04:09 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Apr 21, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,141 | Apr 25, 2011, 04:11 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Apr 21, 2011 | Sale | $58.28 | 4,150 | 241,870 | 139,641 | Apr 25, 2011, 04:11 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Apr 01, 2011 | Option Exercise | $48.74 | 20,555 | 1,001,851 | 377,437 | Apr 05, 2011, 04:54 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Apr 01, 2011 | Sale | $57.70 | 20,555 | 1,185,987 | 356,882 | Apr 05, 2011, 04:54 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Apr 01, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,141 | Apr 05, 2011, 04:52 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Apr 01, 2011 | Sale | $57.78 | 4,150 | 239,793 | 139,641 | Apr 05, 2011, 04:52 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Mar 21, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 142,141 | Mar 23, 2011, 04:19 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Mar 21, 2011 | Sale | $54.20 | 4,150 | 224,910 | 139,641 | Mar 23, 2011, 04:19 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 09, 2011 | Sale | $57.50 | 2,596 | 149,266 | 41,058 | Mar 11, 2011, 04:29 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 04, 2011 | Option Exercise | $56.51 | 2,243 | 126,741 | 43,654 | Mar 08, 2011, 04:36 PM |
Simmons Wayne R. | Vice President, Operations | Mar 04, 2011 | Option Exercise | $56.51 | 2,194 | 123,972 | 56,960 | Mar 08, 2011, 04:34 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Mar 04, 2011 | Option Exercise | $56.51 | 4,611 | 260,545 | 139,641 | Mar 08, 2011, 04:33 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Mar 04, 2011 | Option Exercise | $56.51 | 11,090 | 626,640 | 356,882 | Mar 08, 2011, 04:32 PM |
Miller Joan Elizabeth | SVP-Pathology & Hosp. Services | Mar 04, 2011 | Option Exercise | $56.51 | 2,742 | 154,937 | 96,582 | Mar 08, 2011, 04:31 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Mar 04, 2011 | Option Exercise | $56.51 | 748 | 42,266 | 16,457 | Mar 08, 2011, 04:29 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Mar 01, 2011 | Option Exercise | $43.49 | 4,150 | 180,479 | 146,752 | Mar 03, 2011, 04:12 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Mar 01, 2011 | Sale | $56.77 | 4,150 | 235,582 | 144,252 | Mar 03, 2011, 04:12 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Mar 01, 2011 | Option Exercise | $48.74 | 20,555 | 1,001,851 | 388,527 | Mar 03, 2011, 04:09 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Mar 01, 2011 | Sale | $56.75 | 20,555 | 1,166,535 | 367,972 | Mar 03, 2011, 04:09 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 18, 2011 | Sale | $57.46 | 8,685 | 499,045 | 45,888 | Feb 22, 2011, 05:02 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 15, 2011 | Option Exercise | $56.82 | 31,272 | 1,776,875 | 322,153 | Feb 17, 2011, 06:18 PM |
Simmons Wayne R. | Vice President, Operations | Feb 15, 2011 | Option Exercise | $56.82 | 4,851 | 275,634 | 49,846 | Feb 17, 2011, 06:04 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 15, 2011 | Option Exercise | $56.82 | 1,654 | 93,980 | 14,081 | Feb 17, 2011, 06:03 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 15, 2011 | Option Exercise | $56.82 | 13,002 | 738,774 | 125,354 | Feb 17, 2011, 06:03 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 15, 2011 | Option Exercise | $56.82 | 4,961 | 281,884 | 45,379 | Feb 17, 2011, 06:01 PM |
Miller Joan Elizabeth | SVP-Pathology & Hosp. Services | Feb 15, 2011 | Option Exercise | $56.82 | 6,063 | 344,500 | 86,974 | Feb 17, 2011, 06:00 PM |
Miller Joan Elizabeth | SVP-Pathology & Hosp. Services | Feb 16, 2011 | Option Exercise | $48.74 | 26,666 | 1,299,701 | 125,899 | Feb 17, 2011, 06:00 PM |
Miller Joan Elizabeth | SVP-Pathology & Hosp. Services | Feb 16, 2011 | Sale | $57.40 | 26,666 | 1,530,628 | 99,304 | Feb 17, 2011, 06:00 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 15, 2011 | Sale | $57.17 | 1,540 | 88,042 | 36,694 | Feb 16, 2011, 04:28 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 11, 2011 | Sale | $57.19 | 18,457 | 1,055,556 | 38,153 | Feb 16, 2011, 04:28 PM |
Simmons Wayne R. | Vice President, Operations | Feb 11, 2011 | Option Exercise | $57.15 | 880 | 50,292 | 41,354 | Feb 14, 2011, 07:45 PM |
Simmons Wayne R. | Vice President, Operations | Feb 10, 2011 | Option Exercise | $57.28 | 918 | 52,583 | 41,664 | Feb 14, 2011, 07:45 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 11, 2011 | Option Exercise | $57.15 | 294 | 16,802 | 11,186 | Feb 14, 2011, 07:44 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 10, 2011 | Option Exercise | $57.28 | 293 | 16,783 | 11,480 | Feb 14, 2011, 07:44 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 11, 2011 | Option Exercise | $57.15 | 880 | 50,292 | 57,986 | Feb 14, 2011, 07:43 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 10, 2011 | Option Exercise | $57.28 | 916 | 52,468 | 58,886 | Feb 14, 2011, 07:43 PM |
PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 14, 2011 | Sale | $57.17 | 1,503 | 85,922 | 56,610 | Feb 14, 2011, 07:43 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 11, 2011 | Option Exercise | $57.15 | 5,545 | 316,897 | 285,956 | Feb 14, 2011, 07:27 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 10, 2011 | Option Exercise | $57.28 | 5,545 | 317,618 | 291,501 | Feb 14, 2011, 07:27 PM |
Miller Joan Elizabeth | SVP-Pathology & Hosp. Services | Feb 11, 2011 | Option Exercise | $57.15 | 1,075 | 61,436 | 76,359 | Feb 14, 2011, 07:27 PM |
Miller Joan Elizabeth | SVP-Pathology & Hosp. Services | Feb 10, 2011 | Option Exercise | $57.28 | 1,207 | 69,137 | 77,043 | Feb 14, 2011, 07:27 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 11, 2011 | Option Exercise | $57.15 | 2,305 | 131,731 | 110,306 | Feb 14, 2011, 07:26 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 10, 2011 | Option Exercise | $57.28 | 2,305 | 132,030 | 112,611 | Feb 14, 2011, 07:26 PM |
Cohen Jon R | SVP and Chief Medical Officer | Feb 10, 2011 | Option Exercise | $57.28 | 1,201 | 68,793 | 24,455 | Feb 14, 2011, 07:25 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 09, 2011 | Option Exercise | $35.53 | 152,000 | 5,400,940 | 449,046 | Feb 10, 2011, 05:07 PM |
MOHAPATRA SURYA N | Chairman, President & CEO | Feb 09, 2011 | Sale | $57.53 | 152,000 | 8,745,122 | 297,046 | Feb 10, 2011, 05:07 PM |
BALDWIN JOHN C MD | Director | Feb 09, 2011 | Option Exercise | $44.76 | 30,000 | 1,342,900 | 40,002 | Feb 10, 2011, 05:06 PM |
BALDWIN JOHN C MD | Director | Feb 09, 2011 | Sale | $57.56 | 30,000 | 1,726,881 | 10,002 | Feb 10, 2011, 05:06 PM |
ZIEGLER JOHN B | Director | Feb 08, 2011 | Option Exercise | $46.87 | 21,180 | 992,730 | 37,884 | Feb 09, 2011, 04:36 PM |
ZIEGLER JOHN B | Director | Feb 08, 2011 | Sale | $58.57 | 21,180 | 1,240,426 | 16,704 | Feb 09, 2011, 04:36 PM |
WILENSKY GAIL R | Director | Feb 07, 2011 | Option Exercise | $29.53 | 20,000 | 590,524 | 35,226 | Feb 09, 2011, 04:35 PM |
WILENSKY GAIL R | Director | Feb 07, 2011 | Sale | $58.57 | 20,000 | 1,171,381 | 25,226 | Feb 09, 2011, 04:35 PM |
STANZIONE DANIEL | Director | Feb 07, 2011 | Option Exercise | $29.53 | 20,000 | 590,524 | 36,226 | Feb 09, 2011, 04:33 PM |
STANZIONE DANIEL | Director | Feb 07, 2011 | Sale | $58.92 | 20,000 | 1,178,322 | 31,226 | Feb 09, 2011, 04:33 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 07, 2011 | Option Exercise | $40.63 | 99,287 | 4,034,384 | 214,165 | Feb 09, 2011, 04:32 PM |
HAGEMANN ROBERT | SVP & Chief Financial Officer | Feb 07, 2011 | Sale | $58.92 | 99,287 | 5,849,504 | 114,916 | Feb 09, 2011, 04:32 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 07, 2011 | Option Exercise | $30.54 | 23,694 | 723,624 | 40,054 | Feb 09, 2011, 04:30 PM |
BONGIORNO THOMAS F | VP and Corporate Controller | Feb 07, 2011 | Sale | $58.75 | 28,729 | 1,687,757 | 16,360 | Feb 09, 2011, 04:30 PM |
GLAXOSMITHKLINE PLC | Director | Jan 31, 2011 | Sale | $54.96 | 30,755,151 | 1,690,226,257 | 15,377,551 | Feb 02, 2011, 01:55 PM |
Owner | Relationship | Date | Value($) |
GARDNER MARK A | SVP of Molecular Gen & Oncol | 09/25/2023 | 14,642 |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 08/15/2023 | 10,007 |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 07/25/2023 | 3,615 |
Gregg Vicky B | Director | 07/25/2023 | 11,278 |
Plewman Patrick | SVP for Diagnostic Services | 07/25/2023 | 6,362 |
SAMAD SAM | Executive Vice President & CFO | 07/14/2023 | 547,964 |
Plewman Patrick | SVP for Diagnostic Services | 04/24/2023 | 6,296 |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 04/24/2023 | 3,577 |
Gregg Vicky B | Director | 04/24/2023 | 10,302 |
Plewman Patrick | SVP for Diagnostic Services | 03/24/2023 | 13,291 |
DELANEY MARK E | SVP & Chief Commercial Officer | 03/24/2023 | 22,823 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/06/2023 | 1,270,857 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/06/2023 | 567,930 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/07/2023 | 668,175 |
Doherty Catherine T. | SVP, Regional Businesses | 03/06/2023 | 1,466,328 |
Doherty Catherine T. | SVP, Regional Businesses | 03/06/2023 | 681,635 |
Doherty Catherine T. | SVP, Regional Businesses | 03/07/2023 | 745,899 |
Plewman Patrick | SVP for Diagnostic Services | 03/06/2023 | 381,331 |
Plewman Patrick | SVP for Diagnostic Services | 03/06/2023 | 118,140 |
DEPPE MICHAEL J | SVP, Corp. Controller & CAO | 03/06/2023 | 283,595 |
DEPPE MICHAEL J | SVP, Corp. Controller & CAO | 03/06/2023 | 100,841 |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 03/06/2023 | 293,502 |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 03/06/2023 | 86,202 |
Davis J. E. | CEO and President | 03/06/2023 | 2,248,063 |
Davis J. E. | CEO and President | 03/06/2023 | 1,188,203 |
RUSCKOWSKI STEPHEN H | Director | 03/06/2023 | 12,217,820 |
RUSCKOWSKI STEPHEN H | Director | 03/06/2023 | 5,707,987 |
Doherty Catherine T. | SVP, Regional Businesses | 03/03/2023 | 100,832 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/01/2023 | 45,021 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/02/2023 | 82,154 |
Plewman Patrick | SVP for Diagnostic Services | 03/01/2023 | 12,662 |
DEPPE MICHAEL J | SVP, Corp. Controller & CAO | 03/01/2023 | 9,567 |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 03/01/2023 | 9,145 |
Davis J. E. | CEO and President | 02/23/2023 | 217,798 |
RUSCKOWSKI STEPHEN H | Director | 02/23/2023 | 861,432 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/23/2023 | 119,914 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/24/2023 | 200,109 |
Plewman Patrick | SVP for Diagnostic Services | 02/23/2023 | 36,226 |
DEPPE MICHAEL J | SVP, Corp. Controller & CAO | 02/23/2023 | 27,798 |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 02/23/2023 | 28,833 |
Doherty Catherine T. | SVP, Regional Businesses | 02/23/2023 | 142,241 |
Doherty Catherine T. | SVP, Regional Businesses | 02/24/2023 | 239,000 |
Gregg Vicky B | Director | 02/01/2023 | 9,392 |
Plewman Patrick | SVP for Diagnostic Services | 02/01/2023 | 3,962 |
KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 02/01/2023 | 1,908 |
RING TIMOTHY M | Director | 12/01/2022 | 116,214 |
RING TIMOTHY M | Director | 12/01/2022 | 308,813 |
Doherty Catherine T. | SVP, Regional Businesses | 11/28/2022 | 3,531,472 |
Doherty Catherine T. | SVP, Regional Businesses | 11/28/2022 | 6,081,264 |
RING TIMOTHY M | Director | 11/01/2022 | 122,136 |
RING TIMOTHY M | Director | 11/01/2022 | 288,120 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 10/26/2022 | 833,598 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 10/26/2022 | 2,247,065 |
Gregg Vicky B | Director | 10/19/2022 | 9,447 |
RING TIMOTHY M | Director | 10/03/2022 | 122,450 |
RING TIMOTHY M | Director | 10/03/2022 | 246,780 |
RING TIMOTHY M | Director | 09/01/2022 | 122,450 |
RING TIMOTHY M | Director | 09/01/2022 | 250,040 |
RING TIMOTHY M | Director | 08/01/2022 | 121,709 |
RING TIMOTHY M | Director | 08/01/2022 | 272,080 |
Gregg Vicky B | Director | 07/20/2022 | 9,413 |
RING TIMOTHY M | Director | 07/01/2022 | 114,911 |
RING TIMOTHY M | Director | 07/01/2022 | 266,940 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 05/25/2022 | 2,326,334 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 05/25/2022 | 3,506,934 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 05/24/2022 | 26,601,579 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 05/23/2022 | 7,302,052 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 05/24/2022 | 39,571,320 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 05/23/2022 | 10,858,220 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 05/18/2022 | 1,096 |
Gregg Vicky B | Director | 04/18/2022 | 8,228 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 05/17/2022 | 3,365,672 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 05/17/2022 | 7,082,991 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 03/07/2022 | 327,306 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 03/07/2022 | 118,902 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/07/2022 | 9,130,236 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/07/2022 | 4,237,031 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/07/2022 | 1,501,759 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/07/2022 | 691,558 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/08/2022 | 842,088 |
GUINAN MARK | Executive Vice President & CFO | 03/07/2022 | 2,703,270 |
GUINAN MARK | Executive Vice President & CFO | 03/07/2022 | 1,362,693 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 03/07/2022 | 2,102,515 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 03/07/2022 | 1,033,825 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/07/2022 | 1,742,165 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/07/2022 | 827,372 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/08/2022 | 950,797 |
Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | 03/07/2022 | 2,583,067 |
Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | 03/07/2022 | 1,343,830 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/28/2022 | 85,930 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/24/2022 | 347,215 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/24/2022 | 210,728 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 02/23/2022 | 1,264,530 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/23/2022 | 174,247 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 02/23/2022 | 40,731 |
GUINAN MARK | Executive Vice President & CFO | 02/23/2022 | 308,020 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/23/2022 | 204,831 |
Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | 02/23/2022 | 317,001 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 02/23/2022 | 257,273 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 11/29/2021 | 3,598,539 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 11/29/2021 | 5,890,576 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 07/29/2021 | 909,382 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 07/28/2021 | 13,387,447 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 07/28/2021 | 19,584,846 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 07/29/2021 | 1,337,251 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 07/26/2021 | 556,856 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 07/27/2021 | 3,140,926 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 07/26/2021 | 813,994 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 07/27/2021 | 4,590,550 |
WILENSKY GAIL R | Director | 07/27/2021 | 725,926 |
WILENSKY GAIL R | Director | 07/27/2021 | 1,702,470 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 05/18/2021 | 683 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/09/2021 | 6,736,834 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/09/2021 | 2,987,877 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/09/2021 | 1,130,077 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/09/2021 | 486,726 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/10/2021 | 671,500 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 03/09/2021 | 217,451 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 03/09/2021 | 78,947 |
GUINAN MARK | Executive Vice President & CFO | 03/09/2021 | 1,999,305 |
GUINAN MARK | Executive Vice President & CFO | 03/09/2021 | 739,034 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/09/2021 | 1,304,131 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/09/2021 | 584,718 |
Davis J. E. | EVP, General Diagnostics | 03/09/2021 | 1,912,509 |
Davis J. E. | EVP, General Diagnostics | 03/09/2021 | 961,910 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 03/09/2021 | 1,521,351 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 03/09/2021 | 711,564 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/25/2021 | 92,507 |
Davis J. E. | EVP, General Diagnostics | 02/24/2021 | 97,679 |
Davis J. E. | EVP, General Diagnostics | 02/23/2021 | 151,438 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/24/2021 | 55,141 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/23/2021 | 83,957 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/24/2021 | 138,937 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 02/24/2021 | 12,483 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 02/23/2021 | 19,263 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 02/24/2021 | 74,047 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 02/23/2021 | 123,210 |
GUINAN MARK | Executive Vice President & CFO | 02/24/2021 | 65,564 |
GUINAN MARK | Executive Vice President & CFO | 02/23/2021 | 100,555 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 02/24/2021 | 402,230 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 02/23/2021 | 488,598 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/24/2021 | 63,504 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/23/2021 | 96,435 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 01/04/2021 | 314,160 |
GUINAN MARK | Executive Vice President & CFO | 12/24/2020 | 5,437,592 |
GUINAN MARK | Executive Vice President & CFO | 12/24/2020 | 9,840,673 |
WILENSKY GAIL R | Director | 11/24/2020 | 352,391 |
WILENSKY GAIL R | Director | 11/24/2020 | 770,120 |
STANZIONE DANIEL | Director | 11/23/2020 | 1,417,461 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 10/21/2020 | 598,243 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 10/21/2020 | 1,306,250 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 10/16/2020 | 19,420,721 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 10/16/2020 | 35,039,640 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 10/14/2020 | 1,856,605 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 10/14/2020 | 4,235,329 |
Mendez Manuel O. | SVP & Chief Commercial Officer | 10/06/2020 | 669,353 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 09/02/2020 | 3,883,652 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 09/02/2020 | 6,458,343 |
GUINAN MARK | Executive Vice President & CFO | 06/08/2020 | 5,166,657 |
GUINAN MARK | Executive Vice President & CFO | 06/08/2020 | 8,510,585 |
RING TIMOTHY M | Director | 06/08/2020 | 686,209 |
RING TIMOTHY M | Director | 06/08/2020 | 1,367,718 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 05/18/2020 | 537 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 04/27/2020 | 833,899 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 04/27/2020 | 1,312,433 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 04/27/2020 | 555,075 |
Davis J. E. | EVP, General Diagnostics | 03/16/2020 | 308,251 |
Davis J. E. | EVP, General Diagnostics | 03/10/2020 | 783,439 |
Davis J. E. | EVP, General Diagnostics | 03/10/2020 | 409,445 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/10/2020 | 462,995 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/10/2020 | 231,444 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/11/2020 | 226,744 |
GUINAN MARK | Executive Vice President & CFO | 03/10/2020 | 818,997 |
GUINAN MARK | Executive Vice President & CFO | 03/10/2020 | 412,000 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/10/2020 | 534,216 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/10/2020 | 267,960 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/11/2020 | 260,729 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/10/2020 | 2,670,549 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/10/2020 | 1,479,581 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/10/2020 | 7,117 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/10/2020 | 11,219 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 03/10/2020 | 89,107 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 03/10/2020 | 29,489 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 03/10/2020 | 534,216 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 03/10/2020 | 267,960 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/06/2020 | 16,381,768 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 03/06/2020 | 25,934,978 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/26/2020 | 75,417 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/27/2020 | 75,224 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/26/2020 | 35,660 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/26/2020 | 87,723 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/27/2020 | 86,017 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/26/2020 | 40,881 |
Davis J. E. | EVP, General Diagnostics | 02/26/2020 | 134,012 |
Davis J. E. | EVP, General Diagnostics | 02/27/2020 | 119,922 |
Davis J. E. | EVP, General Diagnostics | 02/26/2020 | 56,656 |
GUINAN MARK | Executive Vice President & CFO | 02/26/2020 | 134,916 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 02/26/2020 | 485,357 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 02/26/2020 | 87,272 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 02/26/2020 | 11,064 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 02/25/2020 | 5,554 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 02/24/2020 | 6,282 |
Davis J. E. | EVP, General Diagnostics | 02/25/2020 | 62,564 |
Davis J. E. | EVP, General Diagnostics | 02/24/2020 | 72,125 |
Davis J. E. | EVP, General Diagnostics | 02/25/2020 | 67,413 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/24/2020 | 42,849 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/25/2020 | 34,795 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 02/25/2020 | 47,943 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 02/24/2020 | 57,768 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 02/25/2020 | 235,067 |
RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 02/24/2020 | 269,657 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/24/2020 | 48,457 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/25/2020 | 40,349 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/25/2020 | 45,656 |
Mendez Manuel O. | SVP & Chief Commercial Officer | 02/24/2020 | 13,797 |
GUINAN MARK | Executive Vice President & CFO | 02/25/2020 | 64,037 |
GUINAN MARK | Executive Vice President & CFO | 02/24/2020 | 73,247 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 01/02/2020 | 164,360 |
Davis J. E. | EVP, General Diagnostics | 01/02/2020 | 9,853,318 |
Davis J. E. | EVP, General Diagnostics | 01/02/2020 | 15,153,865 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 11/27/2019 | 2,453,565 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 11/27/2019 | 4,786,564 |
WILENSKY GAIL R | Director | 11/26/2019 | 446,080 |
WILENSKY GAIL R | Director | 11/26/2019 | 857,352 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 09/17/2019 | 278,250 |
DEPPE MICHAEL J | VP, Corp. Controller & CAO | 09/17/2019 | 530,000 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 06/13/2019 | 12,757,733 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 06/13/2019 | 24,456,500 |
GUINAN MARK | Executive Vice President & CFO | 06/13/2019 | 3,808,306 |
GUINAN MARK | Executive Vice President & CFO | 06/13/2019 | 7,300,500 |
Davis J. E. | EVP, General Diagnostics | 04/24/2019 | 2,886,552 |
Davis J. E. | EVP, General Diagnostics | 04/24/2019 | 4,519,530 |
Davis J. E. | EVP, General Diagnostics | 04/08/2019 | 722,332 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 04/04/2019 | 4,305,216 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 04/04/2019 | 6,013,739 |
Cunningham Everett | SVP, Commercial | 03/01/2018 | 51,445 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 03/01/2019 | 3,330,299 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 03/01/2019 | 1,971,548 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/01/2019 | 577,358 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/01/2019 | 284,380 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/04/2019 | 292,810 |
Klug Robert A | VP, Corporate Controller | 03/01/2019 | 117,695 |
Klug Robert A | VP, Corporate Controller | 03/01/2019 | 36,481 |
GUINAN MARK | Executive Vice President & CFO | 03/01/2019 | 932,529 |
GUINAN MARK | Executive Vice President & CFO | 03/01/2019 | 459,316 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/01/2019 | 666,129 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/01/2019 | 328,070 |
Davis J. E. | EVP, General Diagnostics | 03/01/2019 | 888,144 |
Davis J. E. | EVP, General Diagnostics | 03/01/2019 | 507,176 |
Cunningham Everett | SVP, Commercial | 03/01/2019 | 666,129 |
Cunningham Everett | SVP, Commercial | 03/01/2019 | 328,070 |
Cunningham Everett | SVP, Commercial | 03/04/2019 | 337,865 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 02/26/2019 | 586,420 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/26/2019 | 79,671 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/27/2019 | 90,662 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/26/2019 | 31,690 |
Klug Robert A | VP, Corporate Controller | 02/26/2019 | 12,473 |
GUINAN MARK | Executive Vice President & CFO | 02/26/2019 | 136,679 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/26/2019 | 93,637 |
Davis J. E. | EVP, General Diagnostics | 02/26/2019 | 125,787 |
Cunningham Everett | SVP, Commercial | 02/26/2019 | 97,678 |
Cunningham Everett | SVP, Commercial | 02/27/2019 | 98,967 |
Cunningham Everett | SVP, Commercial | 02/26/2019 | 30,645 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 02/25/2019 | 204,540 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/25/2019 | 27,796 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/25/2019 | 29,645 |
Klug Robert A | VP, Corporate Controller | 02/25/2019 | 4,588 |
GUINAN MARK | Executive Vice President & CFO | 02/25/2019 | 58,238 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 02/25/2019 | 32,031 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/25/2019 | 32,031 |
Davis J. E. | EVP, General Diagnostics | 02/25/2019 | 48,267 |
Cunningham Everett | SVP, Commercial | 02/25/2019 | 38,031 |
Cunningham Everett | SVP, Commercial | 02/25/2019 | 28,763 |
WILENSKY GAIL R | Director | 02/22/2019 | 412,400 |
WILENSKY GAIL R | Director | 02/22/2019 | 702,216 |
Klug Robert A | VP, Corporate Controller | 02/22/2019 | 4,419 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 02/22/2019 | 195,784 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/22/2019 | 25,721 |
GUINAN MARK | Executive Vice President & CFO | 02/22/2019 | 53,918 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 02/22/2019 | 34,649 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 02/22/2019 | 29,699 |
Davis J. E. | EVP, General Diagnostics | 02/22/2019 | 44,725 |
Cunningham Everett | SVP, Commercial | 02/22/2019 | 35,179 |
EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 12/31/2018 | 145,371 |
Klug Robert A | VP, Corporate Controller | 10/12/2018 | 804 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 07/10/2018 | 1,773,082 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 07/10/2018 | 3,480,141 |
Cunningham Everett | SVP, Commercial | 07/10/2018 | 2,870,144 |
Cunningham Everett | SVP, Commercial | 07/10/2018 | 4,516,736 |
Cunningham Everett | SVP, Commercial | 07/02/2018 | 3,699,903 |
Cunningham Everett | SVP, Commercial | 07/02/2018 | 7,465,043 |
LEIDEN JEFFREY M | Director | 05/29/2018 | 173,623 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 05/25/2018 | 9,455,659 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 05/25/2018 | 18,028,430 |
GUINAN MARK | Executive Vice President & CFO | 05/25/2018 | 3,591,374 |
GUINAN MARK | Executive Vice President & CFO | 05/25/2018 | 6,504,682 |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | 03/08/2018 | 2,589,101 |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | 03/08/2018 | 8,717,937 |
GUINAN MARK | Executive Vice President & CFO | 03/02/2018 | 1,326,837 |
GUINAN MARK | Executive Vice President & CFO | 03/02/2018 | 653,571 |
GUINAN MARK | Executive Vice President & CFO | 02/27/2018 | 79,014 |
GUINAN MARK | Executive Vice President & CFO | 02/26/2018 | 147,479 |
GUINAN MARK | Executive Vice President & CFO | 02/23/2018 | 60,792 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 03/02/2018 | 4,422,689 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 03/02/2018 | 2,366,228 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/02/2018 | 821,534 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/02/2018 | 404,606 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 03/05/2018 | 416,928 |
Klug Robert A | VP, Corporate Controller | 03/02/2018 | 137,865 |
Klug Robert A | VP, Corporate Controller | 03/02/2018 | 43,329 |
Davis J. E. | EVP, General Diagnostics | 03/02/2018 | 1,200,486 |
Davis J. E. | EVP, General Diagnostics | 03/02/2018 | 683,164 |
Davis J. E. | EVP, General Diagnostics | 03/05/2018 | 517,322 |
Cunningham Everett | SVP, Commercial | 03/02/2018 | 1,105,849 |
Cunningham Everett | SVP, Commercial | 03/02/2018 | 544,693 |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | 03/02/2018 | 1,105,849 |
Cohen Jon R | SVP & Group Exec. Diag. Sol. | 03/02/2018 | 544,693 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/02/2018 | 1,105,849 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/02/2018 | 544,693 |
Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 03/05/2018 | 561,156 |
RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 02/27/2018 | 306,014 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/27/2018 | 48,889 |
PREVOZNIK MICHAEL E | SVP & General Counsel | 02/27/2018 | 96,501 |
PREVOZNIK MICHAEL E | SVP & General Counsel |